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ABSTRACT
CORA ERIN SMILEY. Interactions between stress, ethanol, and THC exposure
and effects on prefrontal reliant signaling and behavior. (Under the direction of
JUSTIN T. GASS and L. JUDSON CHANDLER).

Post-traumatic stress disorder (PTSD) and substance use disorder (SUD)
are two highly prevalent and highly debilitating psychological conditions that often
occur comorbidly. In accordance with the self-medication hypothesis, drugs like
alcohol and cannabis are used following exposure to a traumatic event to acutely
reduce anxiety, but, in the long term, these substances cause impairments in
learning and memory processes in the prefrontal cortex and reduce the
effectiveness of therapeutic treatments for these disorders. As such, the
overarching hypothesis of this dissertation is that exposure to stress, alcohol, and
cannabis lead to alterations in learning and memory due to modifications in
prefrontal cortex signaling, and it is further hypothesized that these impairments
can be reversed by normalizing glutamatergic function in this region. These
experiments were divided into three main branches of study using behavioral
pharmacology as well as optogenetics and fiber photometry to investigate the
deleterious effects of stress, cannabis, and alcohol exposure on cognitive
functioning and glutamate signaling in the prefrontal cortex. In the first set of
studies, restraint stress was followed by set-shifting and alcohol self-administration
behavioral tasks to examine stress-induced changes in cognitive flexibility and
drug seeking behavior respectively. These experiments established stress induced
xiii

increases in ethanol seeking and relapse like behavior as well as impairments in
cognitive flexibility. The second set of studies established the detrimental effects
of alcohol exposure on fear learning during extinction training. Further, this effect
was shown to be dependent on glutamatergic activity in the prefrontal cortex using
microinjection and optogenetic studies. In the third set of studies, THC vapor and
chronic ethanol administration led to deficits in prefrontal cortex reliant behaviors
including cognitive flexibility, ethanol seeking, and responses to fear stimuli, and
fiber photometry was used to measure effects of these drugs on prefrontal cortex
glutamate signaling. Additionally, the pharmaceutical compounds CDPPB and Nacetylcysteine (NAC) were used to pharmacologically reverse the behavioral and
signaling impairments that occur as a result of alcohol and cannabis exposure
respectively. Taken together, the data presented within this dissertation highlight
the effects of alcohol and cannabis on prefrontal cortex-reliant signaling and
behavior and use clinically available therapeutics to treat these deficits in a model
of PTSD/SUD comorbidity.

xiv

Chapter 1

BACKGROUND AND SIGNIFICANCE

Post-Traumatic Stress Disorder and Comorbidities
Post-traumatic stress disorder was first recognized as a psychiatric disorder
in the DSM-III published in 1980, but its symptomology has been ascribed to a
number of different syndromes that have been defined throughout history (MarcAntonie Crocq 2000). When examining sample populations, lifetime prevalence of
traumatic event exposure reaches approximately 70-89% with instances of
physical or sexual assault, witness of a violent or accidental death, and experience
1

of a disaster or accident being the most commonly reported traumas (Kilpatrick et
al. 2013, Benjet et al. 2016). While a high percentage of the population reports
exposure to a traumatic event, approximately 25-30% of these patients will develop
PTSD (Spottswood et al. 2017). The criterion for a PTSD diagnosis spans 20
symptoms that include hyperarousal, negative mood, avoidance, and reexperiencing the trauma that last for a least a month following exposure to a
stressor (Miao et al. 2018, Kilpatrick et al. 2013, Sareen 2014). Thus, the lifetime
prevalence of PTSD has been reported to reach ~11% in the general population
and 25% in the veteran population (Spottswood et al. 2017). PTSD also has a high
level of impact on the community surrounding the patient, since PTSD is
associated with difficulty parenting, a reduction in income, and children of patients
with PTSD exhibit increased levels of impairments in psychosocial behavior (Miao
et al. 2018, Sareen 2014).
There are a variety of factors that lead to an increased chance of developing
PTSD including female sex, having an adverse childhood experience, previous
drug use, and veteran status (Spottswood et al. 2017, Atwoli et al. 2015,
Christiansen and Elklit 2008, Carlson et al. 2016, Muller et al. 2017). Women are
found to not only develop PTSD at more than twice the rate of men (Olff 2017), but
they develop the disorder at a younger age (Christiansen and Elklit 2008, Smith
and Cottler 2018). These sex differences observed in PTSD are consistent with
the hypothesis that there are innate sex differences in brain activity in response to
stress. Females have been shown to exhibit increased amygdala activation in
2

response to negative stimuli and maintain stronger interconnectivity between the
frontal cortex and the limbic system when compared to men (Helpman et al. 2017).
Therefore, it is crucial to better understand the extent of the sex differences that
occur between these types of patients to differentially tailor treatment regimens for
men and women.
There are three main neuronal circuits that have been shown to be
implicated in the initiation of PTSD and, thus, have become targets for the
treatment of this disorder (Sheynin and Liberzon 2017). First, the fear learning
circuitry, with a focus on the amygdala and medial prefrontal cortex, has been
highly implicated in PTSD with the general hypothesis being that alterations in PFC
signaling results in hyperactivation of the amygdala and exaggerated responses
to fear stimuli (Markowitz and Fanselow 2020, Sheynin and Liberzon 2017,
Kelmendi et al. 2016). Additionally, PTSD is associated with irregularities in the
circuitry that is responsible for context processing including the hippocampus with
connections to the mPFC that are involved in contextual regulation of fear
responses (Kelmendi et al. 2016, Sheynin and Liberzon 2017). The third circuit of
interest includes the emotional regulation pathway from the PFC and amygdala
that, when impaired following stress exposure, leads to the improper regulation of
emotions and contributes to PTSD symptoms (Sheynin and Liberzon 2017). The
only FDA-approved pharmacological treatment for PTSD are selective serotonin
reuptake inhibitors (SSRIs) while the first line psychological treatment is exposure
therapy (Kelmendi et al. 2016, Sheynin and Liberzon 2017). Notably, SSRIs do not
3

treat stress induced alterations in the three circuits described above and have
found to be effective as a PTSD treatment in less than 30% of patients (Alexander
2012, Kelmendi et al. 2016). Recently, further studies have shown that these
medications to not have any effect in the treatment of PTSD in military veterans
when compared to placebo (Kelmendi et al. 2016). Additionally, exposure
therapies have been found to lack efficacy with up to 77% of patients still qualifying
for PTSD diagnosis, ~50% not reporting any change in their symptom severity, and
some patients exhibiting a worsening of symptoms following treatment with
exposure therapy (Markowitz and Fanselow 2020). While exposure-type therapies
are used with the intention to affect plasticity in these fear-associated circuits,
these psychotherapies are often not effective in PTSD patients due to impairments
in the circuitry that allows for extinction learning (Markowitz and Fanselow 2020,
Kelmendi et al. 2016, Sheynin and Liberzon 2017). Therefore, since our first line
treatments for PTSD are often ineffective, recent research has focused on
developing novel treatments to restore normal activity in these circuits to allow for
more effective therapy outcomes (Sheynin and Liberzon 2017, Kelmendi et al.
2016).

4

Alcohol Use Disorder
PTSD often does not occur in isolation, with approximately 90% of patients
with PTSD reporting at least one comorbid psychological disorder (Miao et al.
2018) with the most prevalent including depression, anxiety, or substance use
disorder (Sareen 2014, Muller et al. 2017, Carlson et al. 2016). In patients with
PTSD, alcohol is one of the most commonly used substances to decrease the
feelings of heightened anxiety and arousal experienced with PTSD symptoms
(Smith and Cottler 2018). The common occurrence of these symptoms in PTSD
patients can often lead to alcohol use disorder (AUD), which is recognized when
drinking reaches a rate of over five drinks per day for males and four for females.
This disorder is marked by a series of physiological and neurological symptoms
that are generally a result of the effects of ethanol on cellular toxicity in the brain
and periphery (Kranzler and Soyka 2020, Wackernah et al. 2014). Alcohol is one
of the most commonly used illicit substances, and the 12-month prevalence of AUD
has been recently shown to reach levels as high as 13.9% with lifetime prevalence
of ~36% (Grant et al. 2017). Importantly, rates of AUD differ between the sexes,
with males reporting double the rate of AUD when compared to females (Kranzler
and Soyka 2020).
While alcohol use disorder alone is one of the most common psychiatric
disorders, AUD in PTSD patients is observed at rates up to 79% (Pietrzak et al.
2011). Broadly, there are two main theories regarding the bidirectional relationship
between comorbid PTSD and AUD with evidence to support both hypotheses.
5

First, it has been widely reported that AUD develops following PTSD in accordance
with the self-medication hypothesis where alcohol is being used to decrease
anxiety (Smith and Cottler 2018). This hypothesis has been observed in both
epidemiological research, where a PTSD diagnosis predicts the later development
of AUD (Breslau et al. 2003), and in clinical studies, where patients with PTSD
report increased alcohol cravings following the presentation of trauma related cues
(Coffey et al. 2002). More recently, an alternative hypothesis has been suggested
under which patients with substance use disorders are more likely to experience a
traumatic event and, thus, develop PTSD than non-users (Cottler et al. 1992).
Additional epidemiological studies have also found sex differences in this effect,
where drug use has been shown to be initiated prior to trauma exposure in males
but not females (Cottler et al. 2001).
PTSD and AUD interact in a complex manner to affect cognition and has
led to the characterization of AUD and PTSD as disorders of learning and memory
(Hyman 2005; Vanelzakker et al. 2013). As mentioned above, alcohol can be used
as an anxiolytic by PTSD patients to acutely reduce the intense anxiety
experienced following PTSD symptoms such as nightmares or re-experiencing the
trauma. Theoretically, a cycle occurs where alcohol is used to alleviate PTSD
symptoms but instead renders the fear memory resistant to extinction (Figure 11). This ultimately leads to increased alcohol consumption, the development of
AUD, and the progression of cognitive deficits that exacerbate these disorders.
This theory follows the self-medication hypothesis and is further supported by both
6

clinical (Kessler et al. 1995; Sundin et al. 2014) and preclinical (Meyer et al. 2013)
studies. Essentially, chronic and high-volume alcohol intake can affect cognitive
functioning and worsens PTSD symptoms by interfering with the learning and
memory processes that are responsible for the extinction of trauma associated
cues (Back et al. 2006) Therefore, it is important to examine the underlying circuitry
that overlaps between these two disorders to establish potential targets for the
treatment of comorbid PTSD/AUD.

7

Due to the pervasive effects of alcohol exposure on the brain, the
neurocircuitry underlying the initiation and maintenance of AUD is widespread. The
glutamatergic system is highly involved in the reinforcing effects of alcohol through
downstream activity in key brain regions including the nucleus accumbens and
amygdala (Gilpin and Koob 2008, Koob and Volkow 2018). Additionally, the PFC
has been highly studied with regards to addiction due to its functions in executive
control and ability to modulate dopamine from the reward circuits originating in the
striatum (Volkow et al. 2011, Koob and Volkow 2018). Glutamatergic signaling at
both NMDA as well as metabotropic glutamate receptors subtype 5 (mGlu5) is also
involved in the addiction process due to their role in increasing plasticity throughout
the brain (Gilpin and Koob 2008). Additionally, alcohol has been shown to have
effects on glutamatergic signaling throughout neuronal stress systems which leads
to alterations in both behavioral responses to stressors as well as dysregulation of
this circuitry (Gilpin and Koob 2008, Volkow et al. 2011, Koob and Volkow 2018).
While AUD is highly prevalent and one of the leading causes of preventable
deaths, there is a three-pronged barrier to treating this disorder since there is a
lack of effective treatments, an extremely low 8.3% rate of treatment seeking, and
an under prescription of pharmacological treatments (Kranzler and Soyka 2020,
Ray et al. 2020, Witkiewitz et al. 2019, Swift and Aston 2016). Additionally, the
symptoms that are experienced during alcohol withdrawal are highly aversive
including nausea, anxiety, tremors, and life-threatening seizures (Swift and Aston
2016, Witkiewitz et al. 2019). Currently, there are four pharmaceutical treatments
8

approved by the FDA for the treatment of AUD. Generally, the therapeutic
approach behind these treatments depends on lessening the rewarding properties
of alcohol use by inducing deleterious side effects as a consequence of alcohol
use (Swift and Aston 2016). Over time, the pairing of alcohol with these side effects
leads to an aversive response to alcohol and decreased use (Witkiewitz et al.
2019, Swift and Aston 2016). Due to the unpleasant nature of these drug
treatments, adherence and long-term use of these medications are difficult to
achieve in the AUD population (Swift and Aston 2016). With regards to
psychological treatments, cue-exposure therapy is often used for the treatment of
substance use disorders (Ray et al. 2020, Chambless and Ollendick 2001,
Mellentin et al. 2017). Such treatments rely on the presentation of alcoholassociates cues and stimuli in the absence of any alcohol reinforcer so that over
time patients lose their enhanced responses to alcohol related cues (Byrne et al.
2019, Mellentin et al. 2017, Ray et al. 2020). This method of therapy is theoretically
sound but does not take into account the fact that patients with AUD have deficits
in plasticity and cognition as a result of alcohol intake and, therefore, are not able
to fully respond to cue exposure therapies (Ray et al. 2020, Conklin and Tiffany
2002). Thus, recent research has been focused on using pharmacological agents
to enhance cognition and increase the efficacy of cue exposure therapies for the
treatment of AUD (Ressler et al. 2004, Ray et al. 2020, Vengeliene et al. 2008).

9

Cannabis Use Disorder
In addition to alcohol, cannabis use is also highly prevalent in patients with
PTSD (Hasin et al. 2016). As public perception of cannabis remains positive, with
trends towards legalization growing across the country, cannabis use has been
steadily rising with rates of drug use at 4.1% in 2002 increasing to 9.5% in 2013
(Hasin et al. 2015). Not only has cannabis become one of the most commonly
abused substances, concentrations of delta-9 tetrahydrocannabinol (THC), the
psychoactive component of the drug, have increased as well. In the 1990’s, the
concentration of THC in common cannabis strains was ~2%, but more recently
THC concentration has been recorded to be 17-28% in the most popular strains in
Colorado dispensaries (Stuyt 2018, Lafaye et al. 2017, Licata et al. 2005).
Importantly, while the THC concentration has been sharply increasing, the
cannabidiol (CBD) concentration in cannabis has decreased from 0.5% to 0.090.2% (Stuyt 2018, Lafaye et al. 2017). This is especially concerning considering
the fact that the determinantal effects of cannabis are directly related to the amount
of THC while CBD can have a protective effect on the adverse effects of THC
(Niesink and vanLaar 2013, Lafaye et al. 2017). Chronic use of high-THC cannabis
has been shown to cause deficits in cognition, increased anxiety and psychosis,
and a higher chance of developing cannabis use disorder (CUD) (Volkow et al.
2014, Lafaye et al. 2017, Fergusson and Boden 2008). While 9% of people who
use cannabis will develop CUD, this rate increases to 25-50% in those who start
using in adolescence (Volkow et al. 2014). Earlier cannabis use is also associated
10

with further adverse effects including comorbid psychiatric disorder, reduced life
satisfaction, and cognitive impairment (Fergusson and Boden 2008, Rey et al.
2002), most likely due to ongoing brain development, including the maturation of
synaptic connectivity and the endocannabinoid system, that continues throughout
mid- to late-adolescence (Tortoriello et al. 2014, Volkow et al. 2014, Berghuis et
al. 2007, Keimpema et al 2011).
While cannabis is one of the most commonly used elicit substances, it has
only recently been recognized to have the potential to lead to CUD (Brezing and
Levin 2017, Panlilio and Justinova 2017). Therefore, research dedicated to the
treatment and reduction of harm in CUD has not been fully examined. Although
research regarding cannabis use has been growing since the early 2000s, there
are currently no FDA-approved treatments for CUD (Brezing and Levin 2017).
While CUD alone is associated with adverse consequences, this disorder is also
highly comorbid with other substance use and psychiatric disorders that lead to
further impairments in cognition. Those with CUD have been shown to have up to
a 10x greater chance of developing AUD and a 6x greater chance of developing
PTSD than those without CUD (Hasin et al. 2015, Hasin et al. 2016). Additionally,
there is a bidirectional relationship observed with PTSD and CUD and, in states in
which cannabis is legalized, up to 38.5% of their users cite PTSD symptoms as
their reason for obtaining the drug (Yarnell 2015, Mizrachi Zer-Aviv et al. 2016,
Wilkinson et al. 2015). Additionally, CUD rates are especially high among veterans
who have developed PTSD following trauma exposure (Khoury et al. 2010).
11

Acutely, cannabis can have an anxiolytic effect for PTSD patients, but prolonged
and frequent cannabis use also leads to an increased risk of developing CUD
along with impairments in prefrontal cortex reliant cognition. This is observed
especially in adolescents, where marijuana is the most commonly used illicit
substance by adolescents with PTSD (Yarnell, 2015), and an adolescent with
PTSD has a two-fold increase in the likelihood of developing CUD (Bujarski et al.,
2012). While cannabis acutely acts to decrease anxiety, use of this drug is often
associated with worse symptoms outcomes in patients with PTSD, potentially due
to long term effects on learning and memory through impairments in the developing
prefrontal cortex (Wilkinson et al. 2015). While the presence of comorbid CUD,
AUD, and PTSD is firmly established, there has been a lack of pre-clinical research
into the underlying brain mechanisms that contribute to the maintenance and
treatment of these co-morbid disorders.
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Animal Models of PTSD, AUD, and CUD
While the prevalence of AUD, PTSD, and CUD is extremely high, the
current therapies and pharmaceutical treatments for these disorders do not often
have a high rate of efficacy (Kelmendi et al. 2016). Therefore, it is especially
important to complete preclinical research using translational methods to
investigate the underlying mechanisms responsible for the initiation and
maintenance of these disorders. As such, a variety of different animal models have
been developed to mimic these disorders in rodents. While there are multiple
appropriate models that could be used to depict AUD and PTSD in rats, the models
used for these studies were specifically selected due to their ability to longitudinally
measure changes in fear learning and memory.
To employ a valid model of PTSD, it should depend on the same underlying
neurocircuitry that is involved in fear responses between humans and rodents,
induce behavioral responses to fear associated cues, and mimics the initiation of
the disorder following exposure to a pivotal experience that induces extreme levels
of stress (Flandreau et al. 2017, Goswami et al. 2013). A preclinical model of PTSD
in rodents should allow for longitudinal studies of symptoms induced by stress
exposure and require only a short duration of exposure to a stressful event to
induce PTSD-like symptoms (Siegmund and Wotjack 2006, Goswami et al. 2013).
A variety of tasks have been developed to induce a PTSD-like phenotype in
rodents including restraint stress, single prolonged stress, social defeat stress, and
fear conditioning (Borghans and Homberg 2015, Flandreau and Toth 2018,
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Goswami et al. 2013, Whitaker et al. 2014). While each model has individual
strengths and weaknesses, fear conditioning is the model that best allows us to
address the hypotheses involved in these experiments regarding long-term
relationships between chronic drug exposure and fear related learning and
memory (Ursano et al. 2007; Borghans et al. 2015; Lissek et al. 2015; Singewald
et al. 2019; Mahan et al. 2012; Amstadter et al. 2009). Since the establishment of
conditioning relationships by Pavlov almost one hundred years ago, the ability to
manipulate cue responses has been largely used to study psychiatric disorders
preclinically (Pavlov 1927, VanElzakker et al. 2013). Briefly, conditioning studies
rely on the formation of associations between an unconditioned stimulus (US)
paired with a conditioned stimulus (CS) where subsequent presentations of the CS
will allow the originally unconditioned response (UR) to become a conditioned
response (CR) (Lissek and van Meurs 2014, VanElzakker et al. 2013). This
premise underlies the method of fear conditioning used to induce behavioral
phenotypes similar to PTSD, where a tone and footshock serve as the CS and US
respectively, and the freezing response is the UR that develops into the CR over
time (Lissek and van Meurs 2014). Thus, we can measure the CR over time during
both the conditioning, extinction, and recall phases as well as monitor responses
during these behaviors following chronic drug exposure.
Fear conditioning was followed by binge-like exposure to alcohol in these
experiments to translationally model exposure to a discrete trauma followed by
drug use as self-medication. For our model of AUD, certain aspects of the disorder
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in humans need to be considered, including the level of alcohol consumption,
alcohol dependence, compulsive alcohol seeking, and relapse behavior (Crabbe
2014, Helms et al. 2015, Goltseker et al. 2019). While many different drug selfadministration paradigms have been developed that address the seeking and
relapse aspects of AUD, these protocols will only allow for blood ethanol
concentrations to reach moderate levels since animals will not drink to excess
(Augier et al. 2014, Goltseker et al. 2019). Therefore, a more intensive model has
to be used for studies examining the effects of a high and sustained levels of
ethanol exposure. As such, many investigators now use the chronic intermittent
ethanol (CIE) vapor exposure paradigm to model AUD (Ewin et al. 2019; Holmes
et al. 2012; Sanna et al. 2002; Singewald and Holmes 2019), and it has become
the standard model used to induce alcohol dependence in rats. Furthermore,
individuals with AUD often achieve blood ethanol concentrations (BECs) well
above the legal limit of intoxication similar to the levels achieved in CIE exposure
which could not be established in rodents with voluntary drinking paradigms alone
(Becker 2013; Griffin 2014). As such, CIE exposure was used for the experiments
involved in this dissertation to model the binge-like levels of alcohol exposure
commonly achieved in patients with AUD.
In recent years, cannabis use has been more intensively examined in
preclinical studies. While previously the effects of cannabis have been studied by
testing the effects of CB1 agonists on the brain, more translational models of
cannabis exposure have been developed recently as government regulations
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regarding the use of THC have changed (Panlilio and Justinova 2017). An
additional challenge with modeling cannabis use in animals is that laboratory
animals would not establish self-administration behavior for THC (Lefever et al.
2014, Panlilio and Justinova 2017). Recently, a novel and reliable method THC
self-administration has been established that uses a combination of THC and CBD
as well as a passive vapor exposure to temper the aversive and anxiogenic
aspects of THC administration (Spencer et al. 2019). Not only will rats acquire selfadministration behavior using this model, but they achieve the physiological and
neurological alterations that are often observed as a result of cannabis use
(Spencer et al. 2019). Therefore, the experiments discussed in this dissertation
involve this THC vapor administration model to mimic frequent cannabis intake in
a translationally relevant method.
In summary, while there are many valid animal models that could be used
to replicated these disorders in rodents, we incorporated fear conditioning, CIE,
and THC+CBD vapor exposure as our models of stress, alcohol, and cannabis
exposure to generally study long-term relationships between stress, alcohol, and
cannabis and their impact on the neurocircuitry involved in learning and memory.
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The Prefrontal Cortex
The prefrontal cortex (PFC) is highly involved in both addiction and anxiety
disorders and, therefore, is the target region of study for these experiments. In
humans, the PFC makes up one third of the cortex and has complex structural and
functional organization that allow for its involvement in executive function and topdown control of behavior (Siddiqui et al. 2008, Abernathy et al. 2013). This region
is located in the frontal cortex area anterior to the primary motor cortex and
includes the orbitofrontal, lateral, and medial/cingulate PFC subregions which
maintain reciprocal connections (Abernathy et al. 2013, Radnikow and Feldmeyer
2018). The PFC also sustains long-range projections throughout the brain from
cells across six cortical cell layers (Abernathy et al. 2013). These layers can be
differentiated through distinct anatomical and cellular features and display layerspecific gene expression of different cell types and receptors (Radnikow and
Feldmeyer 2018). While over 80% of the cortex is comprised of glutamatergic cells,
there is layer specific cellular diversity in terms of morphology and signaling
properties that allow these layers to serve distinct functions (Song and Moyer
2018, Little and Carter 2012, Dembrow et al. 2010, Abernathy et al. 2013). For
example, layer V excitatory pyramidal cells are the primary source of PFC output
while layers 1 and 2/3 receive and process signals from axons originating across
a wide range of other brain regions including the thalamus, amygdala, and
hippocampus (Little and Carter 2012, Dembrow et al. 2010). Additionally, although
they make up a smaller percentage of total cells throughout this region, inhibitory
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GABA interneurons are found throughout the PFC and serve to modulate signaling
from the primary pyramidal cells (Abernathy et al. 2013). The diffuse projections
into and out of the PFC allow for control over a wide range of higher order functions
including the planning and direction of behavioral output and attention, active
memory and encoding, and language (Siddiqui et al. 2008, Abernathy et al. 2013).
The control of these functions is distributed throughout the lateral, orbitofrontal,
and medial PFC subregions (Siddiqui et al. 2008, Abernathy et al. 2013).
Generally, the lateral PFC has been shown to be highly involved in the control of
working memory, attention, and cognitive flexibility (Siddiqui et al. 2008, Abernathy
et al. 2013, Szczepanski and Knight 2014), while the orbitofrontal region is known
for its functions in emotional and inhibitory control, decision making regarding
rewards, and reversal learning (Siddiqui et al. 2008, Abernathy et al. 2013,
Szczepanski and Knight 2014). While the functions of the lateral and orbitofrontal
PFC are broadly involved in the circuitry of addiction and anxiety disorders, the
medial PFC (mPFC) is especially important due to its ability to control fear and
drug-seeking behaviors (Siddiqui et al. 2008). Additionally, this region has been
shown to be essential for the exposure-based therapies previously mentioned as
the first-line psychological therapy for conditions like PTSD and AUD (Groblewski
and Stafford 2010). Therefore, in this dissertation, the mPFC and its subregions
are the focus of study due to their established ability to modulate behavioral
responses to drug and fear cues and involvement in the pathophysiology of
PTSD/AUD.
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Prelimbic and Infralimbic Subregions
This dissertation’s focus on mPFC subregions originates from the fact that
patients with PTSD and AUD exhibit alterations in these regions as a result of
stress and alcohol exposure (Suh and Ressler 2018). It is important to note that
mPFC subregions are differentially referenced in humans versus rodents, where
the human dorsal anterior cingulate cortex (dACC) is a correlate of the rodent
prelimbic cortex (PrL) while the human ventro-medial PFC is the infralimbic cortex
(IfL) in the rodent (Milad and Quirk 2012). Generally, the PrL region has been
shown to function in the promotion of fear behaviors while the IfL is involved in
extinction learning by reducing responses to fear stimuli (Milad and Quirk 2012,
Peters et al. 2009). There is a wide range of studies that investigate the PrL that
demonstrate its ability to control responses to fear cues, including signaling studies
where the PrL exhibits increased activity in response to fear cues (Burgos-Robles
et al. 2009) and activation studies where PrL activation or inactivation increases or
decreases the expression of conditioned fear behaviors respectively (Laurent and
Westbrook 2009, Sierra-Mercado et al. 2006, Sierra-Mercado et al. 2011,
Corcoran and Quirk 2007, Vidal-Gonzalez et al. 2006). Additional studies have
shown that there is conditioning induced plasticity exhibited in the PrL (BurgosRobles et al. 2007, Corcoran and Quirk 2007, Mahan and Ressler 2012, Song et
al. 2015) and time-course studies determine that activity in the PrL mirrors the
freezing activity of the animal during conditioning (Gilmartin and Helmstetter 2010,
Milad and Quirk 2016, Burgos-Robles et al. 2009). The PrL has also been shown
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to be highly involved in the top-down control of drug-seeking behaviors (Lasseter
et al. 2010). The contributions of the PrL to drug seeking behavior has been shown
with regards to a wide variety of drugs of abuse including cocaine (Cornish and
Kalivas 2000, McFarland et al. 2003, West et al. 2015), MDMA (Ball and Slane
2012), heroin (LaLumiere and Kalivas 2008, Lasseter et al. 2010), and alcohol
(Palombo et al. 2017, Kroener et al. 2012). These studies highlight the fact that the
PrL is especially important in both the acquisition of drug seeking behavior as well
as cue-induced relapse (Lasseter et al. 2010). Additionally, this function of the PrL
has been shown to involve glutamatergic signaling from this region to the nucleus
accumbens core (NAc), since inactivation of this pathway prevents relapse like
behavior (LaLumiere and Kalivas 2008). Thus, due to the highly overlapping role
of the PrL in both fear expression and promotion of drug seeking behavior, this
region is an important target of study regarding comorbid PTSD and SUD.
Alternately, the IfL has been shown to be involved in opposing the PrL to
allow for reduced responses to fear stimuli by controlling extinction learning (Milad
and Quirk 2016). Initial lesion studies showed that the loss of IfL activity leads to
an inability to retrieve extinction memories (Quirk et al. 2000) while recording
studies demonstrate that IfL signaling is involved during extinction retrieval (Milad
and Quirk 2002), and stimulation of this region reduces the expression of fear
behaviors (Herry and Garcia 2002, Milad and Quirk 2002). Specifically, it has been
shown that extinction memories rely on NMDA activation in the IfL (Burgos-Robles
et al. 2007, Chang et al. 2010) and increased plasticity in this region is required to
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express extinction behavior (Santini et al. 2008). Parallel to its function in the
extinction of fear behaviors, the IfL is also highly involved in the extinction of drugseeking behaviors. IfL projections to the nucleus accumbens shell (NAs) have
been shown to be involved in the suppression of drug seeking behavior (Peters et
al. 2009), stimulation of the IfL has the ability to reduce relapse in reinstatement
tests, and inactivation of the IfL following extinction allows for a return to drug
seeking behavior (Ovari and Leri 2008, Peters et al. 2008). Therefore, as a pivotal
region for the control of extinction of fear and drug-seeking behaviors, the IfL is an
important region to study in terms of the treatment of comorbid PTSD/SUD.

Downstream Signaling Targets
There are a wide variety of downstream regions to which the PrL and IfL
signal to control the expression and suppression of fear and drug-seeking
behaviors (Figure 1-2) (Peters et al. 2009). With regards to the expression of fear
behavior, the PrL is known to signal to multiple subregions of the amygdala through
excitatory glutamatergic projections (Peters et al. 2009, Brinley-Reed et al. 1995,
Vertes 2004, Gabbott et al. 2005). The basolateral amygdala (BLA) is one of the
primary sites of projection from the PrL to control the expression of conditioned
fear behavior (Anglada-Figueroa and Quirk 2005, Herry et al. 2008). Additionally,
there are multiple internal signaling pathways within the amygdala from the lateral
amygdala, the main area responsible for the storage of fear memories, and the
central amygdala, the main source of output from the amygdala, to allow for
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increased amygdala output to downstream regions such as the brainstem and
hypothalamus to increase the presentation of the physiological and behavioral fear
responses (Blair et al. 2001, Repa et al. 2001, Wilensky et al. 2006, Zimmerman
et al. 2007). Alternatively, the IfL also sends glutamatergic projections to the
amygdala, but instead targets the GABA interneurons in the intercalated cell region
of the amygdala that allow for a reduction of activity from the central amygdala
(Berretta et al. 2005, Peters et al. 2009, Jüngling et al. 2008, Likhtik et al 2008).
These amygdala subregions have also been shown to exhibit NMDA-dependent
plasticity as a result of sustained IfL activity during extinction learning (Royer and
Pare 2002). Additionally, these regions have differential projections to the nucleus
accumbens to control addiction related behaviors (Peters et al. 2009). The PrL is
known to signal to the NAc and studies have shown that increased glutamate
release in this pathway can serve as a trigger for the relapse of drug seeking
behavior (Voorn et al. 2004, McFarland et al. 2003, LaLumiere and Kalivas 2008).
Alternatively, the IfL projections to the NAs are responsible for extinction of drug
seeking behaviors shown the correlation of increased glutamatergic plasticity in
this region with extinction behavior as well as inactivation of this circuitry leading
to a return of conditioned drug seeking (Peters et al. 2008, Peters et al. 2009,
Sutton et al. 2003). These regions have been shown to be clinically relevant in
disorders such as PTSD and AUD, where these patients exhibit extinction learning
deficits and hyperactivity in response to fear and drug related cues due to
alterations in these regions (Phelps et al. 2004, Milad et al. 2007, Milad et al. 2008,
Garavan et al. 2000, Coffey et al. 2002). Thus, while this dissertation focuses on
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the contribution of the PrL and IfL to fear- and drug-related behaviors, these
downstream regions are further targets of interest that could be involved in the
results reported herein.

Effects of THC, Ethanol, and Stress on PFC Glutamate Function
Since the PrL and IfL have been shown to be extensively involved in the
control of fear and drug-seeking behaviors, it is important to examine how these
regions are affected by stress and drug exposure to cause the disordered
behavioral responses found in PTSD/SUD (McEwen and Gianaros 2011). Both
acute and chronic stress exposure has been shown to affect glutamatergic
transmission in the prefrontal cortex, and therefore cognitive functioning, through
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increased glucocorticoid release that occurs following stress exposure (Popoli et
al. 2011, Liston et al. 2006). The major glucocorticoid in rodents, corticosterone
(CORT), has been shown to affect baseline glutamate release in the PFC and
acute stress exposure or CORT administration will cause a rapid increase in
glutamate in this region (Karst et al. 2005). Similarly, exposure to chronic stressors
will cause long-term increases in glutamate in the PFC (Moghaddam 1993, Bagley
and Moghaddam 1997). These alterations in glutamate signaling due to stress
exposure will also cause detrimental changes in plasticity in the PFC to amygdala
pathway that lead to lasting changes in behavioral responses to stress (Musazzi
et al. 2015). Additionally, drastic increases in glutamate as a result of stress
exposure can lead to excitotoxicity and cell death in the PFC which further impairs
cognitive function (Popoli et al. 2011).
Alcohol has the ability to affect a wide variety of receptors throughout the
brain to cause pervasive effects on neural function (Abernathy et al. 2010). In the
prefrontal cortex, alcohol has been shown to affect glutamate signaling following
both acute and long-term exposure (Abernathy et al. 2010, Burnett et al. 2015).
Additionally, the severity of alcohol dependence has been corelated with glutamate
levels recorded in cerebrospinal fluid in humans (Umhau et al. 2010). Alterations
in glutamate signaling due to prolonged alcohol exposure have also been shown
to be associated with deficits in cognitive functioning that can last even following
prolonged abstinence periods of over a year (Burnett et al. 2015, Stavro et al.
2013) and the degree of cognitive impairments is correlated with an increased risk
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for relapse (Abbott and Gregson 1981, Bowden-Jones et al. 2005). These alcohol
dependent cognitive deficits have been shown to be a result of maladaptive
changes in glutamate function in the PFC as a result of alcohol exposure (Burnett
et al. 2015, Chandler et al. 1993, Qiang et al. 2007, Kroener et al. 2012). Often,
these neuroadaptations lead to impairments in behaviors such as impulse control
and cognitive flexibility, which lead to deficits in top down control and contribute to
compulsive and high-volume alcohol consumption (Burnett et al. 2015, Kroener et
al. 2012).
In addition to the glutamatergic alterations induced by stress and alcohol
exposure, cannabis has also been shown to affect this system in the PFC
especially when used during adolescence (Cass et al. 2014, Renard et al. 2017,
Schneider et al. 2008). The PFC is highly remodeled during adolescence, including
endocannabinoid and CB1 mediated synaptic pruning to maintain the
excitatory/inhibitory signaling balance (Renard et al. 2017, Caballero et al. 2014,
Thomases et al. 2013). Thus, if CB1 activity is altered through external sources,
such as cannabis, this refinement process can be disrupted leading to long-term
changes in excitatory signaling in the PFC as a result of cannabis exposure (Cass
et al. 2014). Essentially, increased CB1 activity during the adolescent phase of
development impairs the maturation of GABA synapses and subsequently allows
for a hyperactivity of the glutamate synapses in the PFC (Cass et al. 2014, Renard
et al. 2017). Therefore, cannabis use during adolescence could have long-term
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effects on behaviors that depend on the PFC including responses to stress and
drug cues (Meier et al. 2012, Solowij et al. 2002, O’Shea et al. 2004).

Glutamatergic Modulators as PTSD/SUD Treatment
The glutamate system in the PFC has increasingly become a treatment
target for PTSD/SUD due to the high level of involvement of glutamatergic
functioning in this region in the disordered behavioral regulation found with these
disorders. A variety of glutamatergic modulators that target both ionotropic NMDA
receptors as well as metabotropic mGlu5 receptors have been studied as a
treatment for both PTSD and AUD (Averill et al. 2017). Ketamine, an NMDA
antagonist, has recently been explored as a treatment for PTSD and has been
shown to cause significant reductions in the severity of PTSD symptoms when
compared to midazolam, an anxiolytic medication commonly used to treat PTSD
related anxiety (D’Andrea and Sewell 2013, Feder et al. 2014). Additional
therapeutics include d-cycloserine (DCS), a partial agonist at NMDA receptors,
which has been used clinically with variable effects (Difede et al. 2013, Attari et al.
2014). DCS has been used as an adjunct to psychological treatments, including
exposure therapy, to modulate NMDA receptors and plasticity to improve extinction
learning (Averill et al. 2017, Norberg et al. 2008). Similarly, glutamatergic
modulators have been used in the treatment of addictive disorders (Joffe et al.
2018). DCS has also been used for its effects on drug-seeking and has been
shown to facilitate the extinction of this behavior (Botreau et al. 2006). Along with
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targeting

glutamate

receptors

to

enhance

extinction

and

treat

AUD,

pharmacotherapies have been used to target glutamate reuptake at glutamate
transporter 1 (GLT1) to decrease the glutamate spillover often associated with this
disorder (Rao et al. 2015). Specifically, ceftriaxone has been used to increase
GLT1 and has been shown to decrease ethanol consumption as well as attenuate
withdrawal and relapse (Rothstein et al. 2005, Rao and Sari 2012, Sari et al. 2011).
Therefore, due to the role of glutamate in mediating the symptomology of PTSD
and AUD, the studies completed in this dissertation use glutamatergic modulators
to alter the effects of stress and drug exposure on prefrontal cortex reliant signaling
and cognition.
One pharmacotherapy used for these studies is CDPPB (3-cyano-N-(1,3diphenyl-1H-pyrazol-5-yl) benzamide). CDPPB is a positive allosteric modulator of
mGlu5 receptors that has been shown to affect glutamate signaling in the PFC and
behavioral responses to fear and drug related learning paradigms following drug
exposure in preclinical models of PTSD and AUD (Gass et al. 2018, Smiley et al.
2020). Specifically, CDPPB has been shown to enhance the extinction of cocaine
and ethanol seeking behaviors, and these behavioral changes are associated with
enhanced plasticity in the mPFC (Gass and Olive 2009, Cleva et al. 2011, Gass et
al. 2018). In these studies, the effects of CDPPB were shown to be mGlu5
dependent, since infusions of an mGlu5 antagonist into the mPFC prevented the
effects of CDPPB on the extinction of alcohol seeking behavior (Gass et al. 2014).
Thus, due to the highly overlapping underlying circuitry responsible for drug
27

seeking and fear expression, further studies covered under this dissertation utilized
CDPPBs ability to enhance extinction by targeting fear extinction learning.
N-acetylcysteine (NAC) is a clinically available therapeutic that has recently
become a popular treatment for a variety of psychological disorders, including
PTSD and AUD, due to its ability to affect glutamate homeostasis in the brain
(Reissner and Kalivas 2010). Both clinically and preclinically, NAC has been
shown to affect drug seeking behavior, clinically through a reduction in drug use
when administered to veterans with comorbid PTSD/SUD (Back et al. 2017) and
preclinically by reducing stress-cue induced relapse in alcohol self-administration
models (Garcia-Keller et al. 2019). Preclinical studies have also sought to
determine the method through which NAC is exerting these effects. Both stress
and alcohol exposure have been shown to alter the levels of GLT1 and NAC has
been shown to restore GLT1 levels while reducing drug seeking behaviors (Kalivas
and Volkow 2011, Brown et al. 2013). Therefore, due to its ability to normalize
glutamatergic functioning in the brain and effects on treating the deleterious effects
of stress exposure and drug exposure, NAC is a promising candidate for the
treatment of co-morbid PTSD/AUD and needs to be further tested in animal models
to discern the mechanism of action through which it is working to impart these
effects.
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Summary
PTSD and SUD are disorders of learning and memory that involve deficits
in overlapping circuitry in the prefrontal cortex. These disorders often occur
comorbidly due to the anxiolytic properties of drugs such as cannabis and alcohol.
While acutely these substances will decrease the feeling of anxiety, they also lead
to long term alterations in prefrontal glutamate function that can cause a
progression of cognitive deficits that impair the effectiveness of pharmacological
and psychological treatments of PTSD. Therefore, it is increasingly important to
study the prefrontal cortex to determine how stress and drug exposure are
affecting this region and to determine glutamate functioning in this region could
serve as a target for the treatment of PTSD altered by substance abuse.

Statement of Problem and Specific Aims
Post-traumatic stress disorder and comorbid substance use disorder is a
highly prevalent and debilitating reality for many patients. As a result of stress and
drug exposure, there are a variety of deleterious effects on the prefrontal cortex in
terms of signaling and activity as well as behavioral and cognitive consequences.
This is reflected in both clinical and preclinical studies that demonstrate that the
presence of both PTSD and SUD result in worst symptomology as well as
decreased efficacy of both pharmacological and psychological treatment options.
Therefore, it is increasingly important to examine the bidirectional relationship
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between stress exposure and drug use to determine optimal targets for treatment.
The experiments presented within this dissertation use fear conditioning as well as
chronic intermittent ethanol exposure and THC vapor exposure to model PTSD,
alcohol use, and cannabis use to answer questions regarding the effects of drug
exposure on fear learning as well as the effects of stress exposure on drug intake.
The overall hypothesis for these studies is that exposure to THC and ethanol alters
signaling in the prefrontal cortex to affect fear learning and memory and that,
conversely, stress exposure escalates responses to drug related cues through a
similar mechanism. The following aims were designed to test this hypothesis.

SPECIFIC AIM 1: TEST THE HYPOTHESIS THAT STRESS EXPOSURE CAUSES ALTERATIONS
IN

ETHANOL

SEEKING

AND

COGNITION

THAT

CAN

BE

PREVENTED

WITH

N-

ACETYLCYSTEINE.

Following exposure to a traumatic event, patients that develop PTSD often
use substances like alcohol to self-medicate symptoms of anxiety that are often
experienced when exposed to trauma-related cues. Additionally, these patients
experience the development of cognitive deficits that impairs the effectiveness of
psychological treatment options and worsens symptomology. Therefore, to study
this relationship in preclinical models, we used a model of PTSD/AUD using
restraint stress followed by ethanol self-administration to see how prior exposure
to stress effects ethanol seeking during acquisition and reinstatement. Further,
animals were tested in a strategy set-shifting task to assess how stress exposure
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affects cognition. Finally, we tested N-acetylcysteine in a variety of different
treatment schedules to optimize the use of this drug for the prevention of stressinduced alterations in ethanol seeking and cognition.

SPECIFIC AIM 2: TEST

THE HYPOTHESIS THAT CHRONIC ETHANOL EXPOSURE IMPAIRS

FEAR LEARNING THROUGH PREFRONTAL GLUTAMATERGIC MODULATION.

Due to the bidirectional relationship between stress exposure and alcohol
abuse, we next wanted to test the effects of chronic ethanol on fear learning using
an alternate model of PTSD/AUD using fear conditioning and chronic intermittent
ethanol exposure (CIE). First, we tested the effects of CIE on fear extinction
learning and responding during recall testing and then used CDPPB to enhance
extinction learning in these animals. Microinjection experiments were then
completed to determine the neuronal localization of both CIE and CDPPB’s effects
on extinction learning by implanting canulae into either the prelimbic (PrL) or
infralimbic cortex (IfL). Next, we wanted to further investigate the relationship
between chronic ethanol exposure and fear learning by using optogenetics in this
PTSD/AUD model to inhibit either the PrL or IfL during fear memory
reconsolidation to alter fear extinction learning.
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SPECIFIC AIM 3: TEST

THE HYPOTHESIS THAT

THC

INTERACTS WITH ETHANOL AND

STRESS TO INDUCE FURTHER COGNITIVE DEFICITS DUE TO IMPAIRMENTS IN PREFRONTAL
CORTEX GLUTAMATERGIC FUNCTIONING.

Along with alcohol, cannabis is the most highly abused substance by PTSD
patients to acutely reduce anxiety. Additionally, there is an inverse relationship
where cannabis abuse is associated with a higher chance of developing PTSD and
AUD in the future. As such, we then wanted to determine how THC and ethanol
exposure interact to cause deficits in prefrontal cortex reliant behavioral paradigms
including cognitive flexibly, drug seeking, and responses to fear stimuli. Vapor
exposure to both THC and ethanol was followed by testing in strategy set-shifting
procedures, ethanol self-administration, and fear conditioning paradigms to assess
how drug exposure affects behavioral responses to these mPFC dependent tasks.
Further, calcium imaging through fiber photometry was used to assess the activity
of the PrL following exposure to THC and ethanol.
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Chapter 2

N-ACETYLCYSTEINE PREVENTS STRESS INDUCED
ESCALATIONS IN ETHANOL SEEKING AND DEFICITS IN
BEHAVIORAL FLEXIBILITY

Background and Significance
Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are
two psychiatric disorders that have become increasingly prevalent and debilitating
in terms of symptomology and cost to society (Smith and Cottler 2018). Not only
do these conditions cause a variety of incapacitating symptoms, but they often
occur co-morbidly with even worse symptoms and treatment outcomes (Dworkin
et al. 2018; Petrakis et al. 2017). Some of the most common PTSD symptoms
include re-experiencing the trauma through events like flashbacks and nightmares
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that are induced following exposure to cues that are reminiscent of the original
trauma event (Ralevski et al. 2014). In both preclinical and clinical research, it has
been shown that exposure to chronic ethanol can cause deficits in fear cue
extinction learning and memory which can further fear cue associations and allow
for continued maladaptive cue responding in PTSD patients that also have AUD
(Nosen et al. 2015; Vujanovic et al. 2019). Additionally, there are few methods of
treatment available for these disorders and they are often not effective (Flanagan
et al. 2018). Thus, there is a need for further research into the establishment and
maintenance of these disorders to develop pharmacological treatment options for
comorbid PTSD and AUD.
Recent studies have focused on the glutamate system as a target for
treatment of both addictive (Kalivas and Volkow et al. 2011; Gass and Olive 2007)
and anxiety disorders (Averill et al. 2017; Petrakis et al. 2017) as well as their
comorbidity (Verplaetse et al. 2018; Smiley et al. 2020). Exposure to both trauma
and drugs of abuse can have long term effects on plasticity and homeostasis that
can lead to dysregulation of fear and alcohol seeking behaviors in the future (Averill
et al. 2017; Rao et al. 2015; Hwa et al. 2017, Gonzales et al. 1997). In addition to
glutamatergic modulators such as ketamine and D-cycloserine, N-acetylcysteine
(NAC) has become a popular therapeutic to target this dysregulated plasticity to
treat PTSD and AUD (Averill et al. 2017; Tomoko et al. 2018; McClure et al. 2014;
Flanagan et al. 2016). NAC has been used in recent studies that examined the
effect of NAC on PTSD and SUD symptoms in veterans, and NAC treated patients
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reported significant improvements in both drug craving as well as PTSD symptoms
compared to placebo (Back et al. 2016).
Thus, the present experiments examined this relationship in animal models
using restraint stress followed by alcohol self-administration to mimic a discrete
stressor event followed by compulsive alcohol use. NAC was used to reduce stress
cue-induced reinstatement of alcohol seeking, which serves as a preclinical model
of trauma cue exposure induced relapse. These experiments found that exposure
to acute restraint stress contributed to increased alcohol seeking during
acquisition, extinction, and reinstatement and that NAC treatment administered
either before, after, or surrounding the stressor was able to prevent this increased
drug seeking.

Materials and Methods
Animals
Male Wistar rats (PD 52, 250 g on arrival; Charles River Laboratories,
Raleigh, North Carolina) were double housed and habituated to a reverse
light/dark cycle with lights off at 9 a.m. Food and water was available ad libitum
throughout all experiments, except for during behavioral testing (~1-2 hours per
day). Animals had 1 week of acclimation in the colony before any testing or
treatment commenced. All experiments were approved by the Animal Care and
Use Committee of the Medical University of South Carolina and were in
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accordance with guidelines set forth by the National Research Council’s Guideline
for the Care and Use of Mammals in Neuroscience and Behavioral Research
(2003). A total of 120 animals were used across four main experiments and were
broken up into the treatment groups referenced in Table 2-1.

Acute Restraint Stress
Animals were exposed to an acute stressor in the form of a 2-hour restraint
stress exposure session. Each animal was placed into a flat-bottomed Plexiglas
restrainer measuring 3.25 inches in diameter and 8 inches in length and placed
into a new clean cage for the duration of the test. A conical tube cap containing 3
mL of an essential oil was included within each of the cages to be used as a stressrelated cue in further testing. For Experiment 1, a crossover design was used with
regards to stress-paired odor cues where half of the rats were exposed to a
sandalwood scent while the other half received lemon odor exposure while
restrained. Following Experiment 1, which showed that responding was specific to
36

the stress paired and not the unpaired-odor cue, all animals were exposed to
sandalwood odor in further experiments. Sham animals were transferred to new
cages and kept there for two hours in the presence of the odor but were not
restrained. Animals were monitored for differences in body weight and coat texture
in the following weeks to ensure that the stress exposed animals did not differ from
sham animals with regards to heath.

Alcohol Self-Administration
Prior to operant training, all animals were exposed to a two-bottle choice
paradigm that involved a bottle of 20% ethanol along with a bottle containing water
placed on the home cage for three days per week for two weeks to familiarize
animals with the sensory aspects of the drug. Two days following the last twobottle choice session, animals were placed into operant chambers and trained to
lever press for 20% ethanol on an FR-1 schedule of reinforcement based on our
previously published methods (Gass 2014a). Sessions occurred three times per
week and lasted for one hour with each press on the active lever delivering 20%
ethanol in water for 1.5 seconds with the stimulus light illuminated and a tone
presented (2900 Hz, 65 dB). Each active lever press was followed by a 4 second
timeout during which presses were recorded but did not lead to reinforcer delivery.
Once response criteria of 30 lever presses was met (~8-10 sessions), ethanol
concentration was lowered to 10% and criteria of 60 lever presses was met (~12
sessions). Animals completed extinction training once self-administration behavior
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was established (~20 sessions),. During extinction sessions, pressing on the active
lever occurred in the absence of any light/tone cues or ethanol reinforcer.
Extinction criteria was met when lever pressing for each rat was below 20% the
rate of lever pressing recorded on the last two days of self-administration training
(~8 sessions).

Stress Cue-Induced Reinstatement
Animals were put into reinstatement testing following the extinction of lever
pressing behavior. During each 30-minute session, lever presses were recorded
but did not result in light/tone presentation or ethanol delivery. Two reinstatement
tests occurred, one in the presence of the stress paired odor and the second in the
presence of the non-paired order. Using a random crossover design, half of the
animals received their paired odor first while the other half received the non-stress
paired odor during the first reinstatement test. Each reinstatement test was
separated by two subsequent extinction sessions to reduce lever pressing prior to
the second reinstatement test. Experiment 1 established that reinstatement effects
were specific to the stress paired odor and, therefore, all following experiments
used sandalwood odor as the stress paired cue and, thus, only required a single
reinstatement test (experimental design shown in Figure 2-1).
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NAC Administration and Schedules
For all experiments, NAC was administered at a dose of 100 mg/kg and was
prepared the day of injection in 27 mg/mL NaOH in saline and pH was adjusted to
7.2. Vehicle of 0.9% saline was administered to all other animals and injections
were delivered intraperitonially (IP). A variety of different injection schedules were
tested to optimize the timeline of treatment and the effects on the glutamate
system. For Experiment 1, NAC was administered for 4 days prior to and on the
day of reinstatement testing. Experiment 2 involved NAC treatment for 4 days prior
to, the day of, and four days following the restraint stress exposure session, while
Experiment 3 included treatment groups that received either NAC for 4 days prior
to the stressor or for 4 days following the stressor (Figure 2-2).
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Set-Shifting Analysis of Behavioral Flexibility
A between-session strategy set-shift test was used to assess the effects of
stress and NAC exposure on learning, behavioral flexibility was examined using
(Figure 2-3). A separate group of 24 animals were trained to press both the right
and left levers to receive 10% sucrose followed by retractable lever training and
determination of a side preference. Animals were then trained under a first rule
which required animals to respond to the lever that was cued by illumination of the
associated stimulus light and criteria for this rule was met when animals pressed
8 times in a row correctly in a minimum of 30 trials. Once this criterion was met,
animals were tested in a single session under a second rule that required animals
to press on a single lever location regardless of where the light appears. Animals
that take longer to learn the second rule and continue responding for the original
rule are considered to have impaired behavioral flexibility. We also recorded the
type of errors that animals were making during this trial, mainly perseverative
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errors which are presses on the incorrect lever before the animal has made five
correct presses under the second location rule.

Statistics
All analyses were performed using Prism version 8.0 (GraphPad Inc).
Power analyses were completed to determine optimal group sizes with a
significance level of p < 0.05. For single comparisons, analyses used a two-tailed
Student’s t-test while multiple comparisons were completed using two-way
ANOVAs. Repeated measures ANOVAs were used for within subject
comparisons. A Bonferroni post-hoc analysis was performed if the interactions
found in the ANOVAs were significant.
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Results
Exposure to acute restraint stress leads to increases in ethanol seeking
First, we determined the long-term effects of a single acute restraint stress
exposure on ethanol seeking behavior during self-administration, extinction, and
stress-cue induced reinstatement (Figure 2-1). Animals were exposed to a 2-hour
restraint stress or sham stress in the presence of either a lemon or sandalwood
scent to serve as a conditioned odor cue during later phases of training. Following
stress exposure, all animals underwent 2 weeks of two bottle choice for 20%
ethanol before being trained in operant self-administration followed by extinction.
There was no difference between stress and sham animals during two-bottle
choice (Figure 2-4A) or during the first 10 sessions of ethanol self-administration
where animals were still learning ethanol seeking behavior (Figure 2-4B).
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Animals that were previously exposed to restraint stress exhibited
increased ethanol seeking during self-administration following acquisition. These
animals increased lever pressing when compared to sham animals during the last
ten self-administration sessions (Figure 2-5A, two-way RM-ANOVA time F(5, 115)
= 69.97, p < 0.001, stress vs. sham F(1,22) = 68.54, p < 0.001, interaction F(9,198
= 5.803, p < 0.001). Additionally, stress exposed animals also sought more ethanol
reinforcers during these sessions when compared to sham animals (Figure 2-5B,
two-way RM-ANOVA time F(5,115) = 80.64, p < 0.001, stress vs. sham F(1,22) =
58.38, p < 0.001, interaction F(9,198) = 5.512, p < 0.005). This stress-induced
increase in ethanol seeking was also present when examining at the total number
of reinforcers received across the entirety of self-administration (Figure 2-5C, twoway ANOVA stress vs. sham F(1,20) = 347.7, p < 0.001). Following selfadministration, animals were exposed to 8 extinction sessions and stress exposed
animals exhibited increased lever pressing during this phase of training as well
(Figure 2-5D, two-way RM-ANOVA time F(5,105) = 8.35, p < 0.001, stress vs.
sham F(1,22) = 70.83, p < 0.001, interaction F(9,198) = 8.35, p < 0.001).

43

44

Escalations in ethanol seeking during reinstatement following stress exposure are
prevented with NAC treatment
Following the extinction of lever pressing behavior, animals were tested for
reinstatement of alcohol seeking behavior. For 4 days prior to and on the day of
the reinstatement test, animals were administered I.P injections of either 100
mg/kg NAC or Vehicle (0.9% saline). Rats within each exposure group were evenly
distributed into NAC and Vehicle treatment groups so that animals did not differ in
ethanol seeking behavior prior to treatment (two-way ANOVA NAC vs. Veh F(1,20)
= 0.57, p = 0.46). Stress exposed animals exhibited increased lever pressing in
response to the stress paired odor cue during reinstatement when compared to
sham animals, and NAC treatment prior to reinstatement resulted in a decrease in
active lever presses when compared to stressed animals that received vehicle
(Figure 2-6A, three way RM-ANOVA Ext vs. Rst F(1,20), 56.78, p < 0.001, stress
vs. sham F(1,20) = 55.33, p < 0.001, NAC vs. Vehicle F(1,20) = 47.57, p < 0.0001,
interaction F(1,20) = 82.07, p < 0.001). There were no differences in lever pressing
behavior between any of the treatment groups when examining reinstatement
sessions completed in the presence of the odor that was not paired with the
stressor (Figure 2-6B, three-way RM-ANOVA Ext vs. Rst F(1,20) = 2.32, p =0.144,
sham vs. stress F(1,20) = 0.35, p = 0.559, NAC vs. Vehicle F(1,20) = 0.55, p =
0.466, interaction F(1,20) = 0.69, p = 0.416) or in inactive lever presses during the
stress paired (Figure 2-6C) and unpaired odor (Figure 2-6D) reinstatement
sessions.
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NAC treatment surrounding, prior to, and following the stressor all served as
effective treatments
Since NAC can have differential effects on the glutamate system depending
on the timing of treatment, two additional experiments were completed to
determine the treatment schedule that was the most effective at reducing
responding during reinstatement (Figure 2-2). The first experiment involved NAC
administration for 4 days prior to, on the day of, and for 4 days following the
stressor to prevent stress induced changes in glutamatergic functioning. There
were no differences found between any groups in terms of ethanol consumption
during 2-bottle choice (Figure 2-7A) or the first ten sessions of self-administration
(Figure 2-7B). Once animals acquired self-administration behavior, stress
exposed animals exhibited an increase in active lever pressing compared to both
sham exposed animals and those that had been exposed to restraint stress and
treated with NAC surrounding the stressor (Figure 2-7C, two-way RM-ANOVA
NAC vs. Vehicle F(3,28) = 13.72, p < 0.001, time F(9,52) = 248.9, p < 0.001,
interaction F(27,252) = 2.575, p < 0.001). This increase in ethanol seeking was
also reflected by an increased number of reinforcers received across the entirety
of self-administration training by stress exposed animals when compared to Sham
+ Veh and Sham + NAC animals as well as stress exposed animals that were
treated with NAC (Figure 2-7D, one-way ANOVA F(3,28) = 226.7 p < 0.001).
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Following self-administration, lever pressing behavior was extinguished
before animals were put into stress cue-paired reinstatement testing. Again, stress
exposure served to increase active lever pressing during reinstatement in the
presence of the stress paired odor, while NAC treatment administered surrounding
the stressor was able to prevent this heightened ethanol seeking (Figure 2-8A).
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Additionally, there was no differences between any treatment groups in inactive
lever pressing during this reinstatement session (Figure 2-8B). Taken together,
these data suggest that NAC treatment surrounding a stressor is effective at
preventing stress-induced increases in ethanol seeking.

Once NAC was established as an effective treatment when administered
surrounding the stressor, our next experiment was designed to further narrow
down the necessary treatment regimen for NAC. Two different NAC administration
schedules were implemented to determine if NAC treatment either prior to or
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following restraint stress was able to prevent stress induced escalations in ethanol
seeking during self-administration and reinstatement. As such, NAC was
administered for either 4 days before stress and the day of stress or for 5 days
after the stress occurred (Figure 2-2). Again, there were no changes in ethanol
seeking during either 2-bottle choice (Figure 2-9A) or the first ten sessions of selfadministration (Figure 2-9B). Additionally, we were able to replicate the ability of
stress exposure to increase lever pressing during self-administration and NAC
treatment both prior to or following the stressor were effective at preventing
increased ethanol seeking (Figure 2-9C, two-way RM ANOVA treatment F(4,350),
P < 0.0001, time F(9,350) = 179, p < 0.001, interaction F(36,350) = 1.83, p <
0.001). This effect was also reflected in the increased number of reinforcers sought
by stress exposed animals that was prevented with NAC treatment either before
or after the stressor (Figure 2-9D, one-way ANOVA F(4,35) = 231.2, p < 0.001).
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Following the extinction of lever pressing behavior, animals were tested in
stress-cue induced reinstatement. During this session, animals that were
previously exposed to restraint stress exhibited increased lever pressing behavior
when compared to all other groups, and animals administered NAC either prior to
or following the stressor did not exhibit this relapse-like behavior (Figure 2-10A,
two-way RM-ANOVA Ext vs. Rst F(1,35) = 57.42, p < 0.0001, treatment F(4,35) =
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28.37, p < 0.0001, interaction F(4,35) = 29.28, p < 0.0001). This behavior was
specific to active lever presses, since there were no differences between any
treatment group in inactive lever pressing (Figure 2-10B).

Stress exposure causes deficits in behavioral flexibility that are prevented with
NAC
An operant set-shifting task was used to determine if stress exposure or
NAC treatment had any effects on operant learning. NAC (100 mg/kg) or vehicle
was delivered for 4 days before, on the day of, and for 4 days following the stressor
and set-shifting training commenced the following week (Figure 2-3). Once
animals were trained to lever press for sucrose under a light cue specific rule, the
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rule was changed to a location specific rule and trials to criteria were measured.
All animals were required to meet criteria for the visual rule in a minimum of 30
trials before being tested in the location rule, and neither NAC treatment or stress
exposure had an effect on initial learning (Figure 2-11A F(3,4) = 0.038, p = 0.989).
Once the rule was switched, stress exposed animals took more trials to meet
criteria when compared to sham exposed animals, signifying an impairment in
cognitive flexibility, and NAC treatment surrounding the stressor prevented this
learning deficit (Figure 2-11A, F(3,20) = 5.77, 0.005). Additionally, we found that
stress exposed animals exhibited an increased number of perseverative errors
when compared to all other treatment groups, and the increase in trials was not
due to animals omitting lever presses (Figure 2-11B, F(3,20) = 4.46, p < 0.015).
Additionally, NAC treatment in the absence of a stressor did not cause any
changes in trials to criteria or perseverative errors. Taken together, these data
indicate that NAC alone does not cause changes in operant learning and can
prevent stress induced deficits in cognitive flexibility.
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Discussion
These experiments conclude that exposure to acute restraint stress causes
escalations in ethanol seeking behavior during self-administration acquisition,
extinction, and stress cue induced reinstatement. Additionally, stress exposure
induces deficits in cognitive flexibility which could be contributing to the
impairments observed in reinstatement testing. Further, NAC was successful at
preventing both escalations in ethanol seeking as well as deficits in cognitive
flexibly when administered either prior to stress, following the stressor, or at both
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time points. These data support the relationship between stress exposure and
increased ethanol seeking and establish NAC as a pharmacological modulator that
is affective at preventing stress induced relapse.
While there are a multitude of brain circuits involved in the establishment
and maintenance of disorders like PTSD and AUD, the prefrontal cortex and its
projections to the nucleus accumbens are especially important for relapse-like
behaviors (Chen et al. 2010). These circuits are also altered following exposure to
drugs of abuse, and this causes a variety of adaptations that can, in turn, reinforce
the maladaptive behaviors that underly substance use (Lüscher and Malenka
2011). In an addiction state, these projections have impaired plasticity which, in
part, is induced by impairments in the regulation of glutamate homeostasis (Kalivas
2009). Importantly, the connections between these regions have been shown to
be involved in the ability to alter behavioral responses to a changing environment
which is involved in the cognitive flexibility processes required for the extinction of
drug-seeking and fear-related behaviors (Spencer et al. 2016). Additionally,
prefrontal plasticity, glutamatergic function, and behavioral output have all been
shown to be affected by exposure to an intensely stressful event (McEwen and
Morrison 2013, Arnsten 2009). In animal models, dendritic morphology in the
prefrontal cortex has been shown to be reduced following exposure to both
pharmacological and behavioral models of extreme stress (Cook and Wellman
2004), and this reduction in structural plasticity results in impaired functional
plasticity as well (Jackson and Moghaddam 2006, Radley et al. 2015). These
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underlying changes in plasticity and glutamatergic functioning in the projections
from the prefrontal cortex to the accumbens could play a role in the behavioral
affects observed on drug seeking and reinstatement following exposure to restraint
stress in these studies.
NAC has been shown to modulate the brain through a number of different
mechanisms. Primarily, the ability of NAC to affect the glutamatergic system has
been the focus of its use for the treatment of addiction and anxiety disorders (Ooi
et al 2018; McClure et al. 2014; Kupchik et al. 2012; Tomko et al. 2018; Zhou et
al. 2008). NAC has been shown to affect glutamate homeostasis through multiple
mechanisms including regulation of the cysteine-glutamate and glia glutamate
transporters (Kupchik et al. 2013; Ooi et al 2018; Zhou and Kalivas 2009). Both of
these glutamatergic modulators are impaired followed drug exposure and reduced
expression of these transporters is associated with the reinstatement of drugseeking (Ooi et al. 2018). Specifically, NAC could be acting through these
glutamatergic mechanisms to prevent stress cue induced relapse in these studies.
Additionally, NAC has the ability to regulate antioxidant tone and multiple pro- and
anti-inflammatory mediators (Minarini et al. 2017; Ooi et al. 2018; Šalamon et al.
2019; Tardiolo et al. 2018; Mokhtari et al. 2017; Uraz et al. 2013; Sadowska et al.
2007). Specifically, NAC has the ability to reduce levels of pro-inflammatory
mediators such as TNF-a (Peristeris et al. 1992), IL-1b (Palacio et al. 2011), nitric
oxide synthase (Bergamini et al. 2011), and activated microglia (Karalija et al.
2012), and increases anti-inflammatory factors (Bavarsad-Shahripour et al. 2014).
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Since exposure to chronic ethanol (Fernandez-Lizarbe et al. 2009; Marshall et al.
2016) and stress (Walker et al. 2013; Maydych 2019; Voorhees et al. 2013) has
been shown to have the opposite affect by increasing pro-inflammatory factors,
NAC acting as an antioxidant and anti-inflammatory agent could work to prevent
the deleterious behavioral consequences that occur as a result of PTSD and AUD.
While these experiments examined the behavioral effects of restraint stress
exposure on ethanol seeking behavior and cognitive flexibility as well as the
established the ability of NAC to treat these deficits, further studies need to be
completed to determine the mechanism of action though which NAC is working to
impart these effects.
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CHAPTER 3

INFRALIMBIC MGLU5 SIGNALING MEDIATES THE
DELETERIOUS EFFECTS OF CHRONIC INTERMITTENT
ETHANOL EXPOSURE ON EXTINCTION LEARNING

Background and Significance
Post-traumatic stress disorder (PTSD) is one of the most highly observed
conditions that occurs in patients that are in treatment for substance abuse and,
as such, the rates of comorbidity between PTSD and alcohol use disorder (AUD)
have been recorded to reach rates as high as 41–79% (Pietrzak et al. 2011).
Additionally, there is greater clinical and functional impairment observed in those
with both PTSD and AUD when compared to either disorder alone (Lehavot et al.
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2014), and there is evidence that PTSD symptoms are a significant risk factor for
AUD which, in turn, interferes with PTSD treatment (Gaher et al. 2014). An
additional area of interest with regards to comorbid PTSD/AUD focuses on
differences between the sexes since these disorders often have different clinical
profiles between men and women (Lebron-Milad and Milad 2012, Sonne et al.
2003). Along with these clinical observations, preclinical examinations of sex
differences in PTSD models have observed sexual dimorphisms in heritability,
receptor expression, neuronal structure, and fear circuit functionality (Ramikie and
Ressler, 2017). Therefore, for the purpose of these studies, an examination of sex
differences was included to determine any differences in responses to fear stimuli
following chronic ethanol.
AUD and PTSD can often be classified as disorders of learning and memory
(Hyman 2005; Vanelzakker et al. 2013) due to the complex interactions between
alcohol and stress exposure in the prefrontal cortex. While alcohol can be abused
by PTSD patients to help acutely alleviate their anxiety symptoms, in the long-term,
alcohol abuse worsens PTSD symptoms and induces cognitive deficits that
interfere with the extinction of trauma associated cues (Back et al. 2006).
Additionally, these data reveal that anxiety disorders such as PTSD are affected
by repeated alcohol use (Tipps et al. 2013), and chronic alcohol use also affects
PTSD memories. Importantly, the first line behavioral therapies for both PTSD
(Kessler et al. 1995) and drug addiction (Conklin and Tiffany 2002), including
extinction-based exposure therapies, depend on these basic principles of learning
and memory. Therefore, due to impairments in these processes associated with
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chronic alcohol exposure following stress, these therapies often have limited
efficacy for these patients. Thus, targeting these learning and memory impairments
with pharmacological modulators could serve to increase the effectiveness of
these therapies in the treatment of comorbid PTSD and AUD. Following this line
of research, previous studies in our lab have targeted the extinction phase of
memory using cognitive enhancers that increase metabotropic glutamate receptor
5 (mGlu5) activity to facilitate learning during this time (Cleva et al. 2011, Gass et
al. 2014a, Gass and Olive 2009a). Additional studies have used mGlu5 modulators
to enhance plasticity in the medial prefrontal cortex (mPFC) and demonstrate that
mGlu5 mediated plasticity in the infralimbic subregion is necessary to block the
expression of fear behaviors to allow for successful extinction (Fontanez-Nuin et
al. 2011, Sepulveda-Orengo et al. 2013).
Overall, the literature makes it clear that there is an interaction between
alcohol exposure, fear extinction learning, and glutamate signaling in the IfL, but
the exact nature of this relationship in comorbid PTSD/AUD is not clear. Therefore,
the purpose of these experiments was to determine the effects of chronic
intermittent ethanol vapor exposure on the extinction and recall of conditioned fear
responses and to utilize manipulation of prefrontal glutamatergic systems to
reverse these effects. An additional area of study within these experiments focuses
on potential differences between males and females in responses to fear stimuli
given the substantially different rates of prevalence of these disorders between the
sexes.
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Materials and Methods
Animals
These experiments used male and female Wistar rats [postnatal day (PD)
50 and 250-275 g upon arrival, Harlan, Indianapolis, IN] who were individually
housed in standard polycarbonate cages. Throughout the experiment, access to
food and water in the home cage was continuous except during behavioral testing.
Animals were habituated to a 12:12 reverse light-dark cycle with lights off at 09:00
am in order for experimental testing to be performed during the dark portion of the
cycle. All experimental procedures were conducted with the approval of the
Institutional Animal Care and Use Committee at the Medical University of South
Carolina and within guidelines set forth by the National Research Council’s
Guideline for the Care and Use of Mammals in Neuroscience and Behavioral
Research (2003). A total of 96 animals across seven treatment groups for each
sex were used in total for Experiments 1 and 2. Experiment 1 consisted of
behavioral experiments completed using fear conditioning followed by CIE
exposure and required three groups per sex that received the following treatments:
Air+Vehicle, CIE+Vehicle, and CIE+CDPPB (n=8/sex, 48 animals total).
Experiment 2 replicated these behavioral studies and also included treatment
groups that received surgery to implant a microinjection canula for further
manipulation, and required four groups that received the following treatments:
CIE+Vehicle,

CIE+CDPPB,

CIE+CDPPB+MTEP

in

the

IfL,

and
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CIE+CDPPB+MTEP in the PrL (n=6/sex, 48 animals total). The overall
experimental design timeline is depicted in Figure 3-1.

Drugs
3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB) was custom
synthesized by Chemir Analytical Services (Maryland Heights, MO) according to
previously published methods (Kinney et al. 2005, Lindsley et al. 2004), purified to
>95% purity by liquid chromatography-mass spectrometry, and suspended in 10%
v/v Tween-80 (Sigma-Aldrich). CDPPB was administered at a dose of 30 mg/kg
and all injections were delivered subcutaneously. Previous studies in our lab have
shown that 30 mg/kg CDPPB has the ability to facilitate extinction learning without
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resulting in any motor effects (Cleva et al. 2011, Gass et al. 2014, Gass and Olive
2009a). MTEP [3-((2-Methyl-4-thiazolyl) ethynyl)pyridin hydrochloride] was
purchased from Abcam Inc. (Cambridge, MA) and dissolved in sterile artificial
cerebrospinal fluid (aCSF) to reach a final concentration of 5 μg/μl. This dosage is
based on our previously published findings and was chosen to maximize blockade
of mGlu5 receptor activity (Cannady et al. 2017, Gass et al. 2014, Sinclair et al.
2012). Additionally, there have been no locomotor effects reported using similar
doses of MTEP (Klodzinska et al. 2004, Martin-Fardon et al. 2009).

Fear Conditioning Protocol
Fear conditioning paradigms were completed following the protocol used in
previously published works (Cain et al. 2002, Holmes et al. 2012, Izquierdo et al.
2006, Sinclair et al. 2012, Wellman et al. 2007). Conditioning trials occurred once
a day for a total of three days and lasted approximately five minutes per session
to preclinically model characteristics of PTSD (Cain et al. 2012, Vanelzakker et al.
2013). Each session consisted of a 120 second acclimation period, followed by
four pairings of the tone (conditioned stimulus, CS, 30 sec, 80 dB, 3 kHz tone) with
the footshock (unconditioned stimulus, US, 2 sec, 0.75 mA scrambled footshock)
presented during the last 2 seconds of the tone. A 10 second inter-stimulus interval
separated each tone/shock pairing. Conditioning criteria was met when rats
displayed freezing behavior at least 80% of the time during the presentation of the
CS. FreezeScan software (Clever Systems, Inc.) was used to determine freezing
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behavior from digitized videos (Milad and Quirk 2012, Sierra-Mercado et al. 2011,
Quirk and Mueller 2008, Quirk et al. 2010). Treatment groups were behaviorally
matched to ensure that all groups had similar levels of freezing prior to further
manipulation.

Chronic Intermittent Ethanol (CIE) Exposure
CIE exposure was started following the completion of fear conditioning to
model alcohol dependence that starts in response to the experience of a traumatic
event and required repeated cycles of exposure to binge-like levels of ethanol
through vapor inhalation. This is a highly characterized model of ethanol exposure
that has been used by our lab (Gass et al. 2017, Trantham-Davidson et al. 2014)
and others (Sanna et al. 2002, Ewin et al. 2019, Holmes et al. 2012, Singewald
and Holmes 2019) to study the effects of chronic ethanol on the brain and behavior.
For CIE exposure, animals were placed into an ethanol vapor chamber for 14
hours a day for 14 consecutive days which left 10 hrs. of abstinence per day. As
the rats were on a reverse 12-hour light/dark cycle with lights on at 9:00 pm and
off at 9:00 am, CIE was planned to occur mostly during the lights on phase (6 pm
to 8 am). To make sure that CIE did not have deleterious effects on the health of
the animals, body weight and water intake were monitored throughout exposure.
Animals in the control groups were transferred to the lab to remain in their home
cages during the time period in which CIE animals were in the chambers.
Intoxication levels were measured per rat at the end of each vapor exposure period
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using a 5-point motor intoxication rating scale (Nixon and Crews 2002) with a target
of slight-to-moderate motor intoxication, or a rating of 2 to 3, respectively. BECs
were determined from tail blood using a standard colorimetric assay at the end of
exposure days 2, 6, 10, 15, using previously published methods (Gass and Glenn
et al. 2014, Gass and Trantham-Davidson et al. 2014, Trantham-Davidson et al.
2017). Fear extinction paradigms began 72 hours after CIE exposure ended to
avoid any effects of alcohol withdrawal.

Fear Extinction Testing
An “ABBA” experimental design was used to determine the effects of CIE
exposure on the extinction of fear responses to both the cue and context. The initial
fear conditioning trials occurred in the original fear box with silver metal walls and
silver grate flooring (context A) and cue extinction occurred in a novel, visually
distinct context (B) that consisted of black paneled walls and solid plastic flooring.
Each extinction session consisted of a 120 second acclimation period followed by
10 presentations of the CS (tone), each lasting 30 seconds and separated by a 10
second inter-stimulus interval. Extinction criteria was met when animals froze, on
average, less than 30% of the time in response to the CS for 3 consecutive
presentations of the CS. For those in the drug treatment groups, animals received
CDPPB (30 mg/kg, subcutaneously) or vehicle (10% Tween-80, subcutaneously)
20 minutes prior to each extinction session while all further testing was completed
in a drug free state.
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Extinction Cue Recall and Context Recall
Following the successful extinction of freezing behavior, animals were
tested for extinction cue recall by placing them in the extinction environment
(context B) and exposing them to a single tone presentation. These trials lasted
for a total of 150 seconds, including a minute prior to and a minute following the
30 second tone, and freezing behavior was measured in response to the tone.
Subsequently, animals were tested for context-induced recall of freezing behavior
by placing them in the original fear context A without presentation of the tone (Elias
et al. 2010, Tovote et al. 2015). These tests were both included to determine the
effects of CIE exposure on the retention of extinction learning for fear-associated
cues and environments.

Stereotaxic Microinjection Cannula Implantation
For Experiment 2, a separate group of 48 rats performed the same
behavioral paradigms, but with the addition of treatment groups that received
microinjections of MTEP, an mGlu5 negative allosteric modulator, in the IfL or PrL
to determine if CDPPB induced increases in mGlu5 activity in these regions is
responsible for its facilitation of fear extinction learning. Surgeries to implant
bilateral microinjection canula commenced between PD 50 and 56 and rats were
allowed two weeks of recovery before beginning behavioral testing. Isoflurane was
vaporized in medical grade breathing air at a flow rate of 0.4 L/min to anesthetize
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animals before placing them in a stereotaxic instrument (Kopf Instruments,
Tujunga, CA). The microinjection cannula (26 ga O.D., Plastics One, Roanoke,
VA) was implanted 1 mm dorsal to the IfL or PrL cortex, and the following
stereotaxic coordinates were used: anterior/posterior + 3.24, medial/lateral ± 0.6,
and dorsal/ventral − 3.8 for the IfL and anterior/posterior + 3.24, medial/lateral ±
0.6, and dorsal/ventral −2.2 for the PrL (in mm from bregma and skull surface)
(Paxinos and Watson 2005). Stainless steel screws were placed into the skull and
were covered with dental cement to secure the microinjection cannula in place. To
prevent tissue obstruction and contamination from debris, removable obturators
(33 ga O.D.) were inserted in the full length of the guide cannula. Following
surgery, the incision was sutured using 3-0 Vicryl sutures and treated with 2%
xylocaine and 2% triple antibiotic ointments topically. Post-operative care
consisted of daily injections of carprofen (2.5 mg/kg, s.c. for 5 days) for pain
management. Once animals were allowed at least two weeks for surgical recovery,
they were exposed to our model of PTSD/AUD through fear conditioning followed
by CIE.

Microinjection Procedures
Microinjections of 5 μg/μl MTEP into either the PrL or IfL were completed 25
minutes prior to each extinction session. Animals were lightly restrained to remove
the obturators and insert sterile 33-gauge microinjection needles (Plastics One)
connected through microbore tubing to two 100 μl syringes (Hamilton, Reno, NV).
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A micro-infusion pump held both syringes (Harvard Apparatus, Holliston, MA) and
was set to deliver either MTEP or aCSF at a flow rate of 0.5 μl/min for a total of
one minute. The microinjection needles were inserted to a depth 1 mm beyond the
ventral tip of the guide cannula and were left in place for an additional minute
following drug injection to allow for diffusion. Obturators were replaced following
the removal of the microinjection needles, and animals in the CDPPB groups
received subcutaneous injections (30 mg/kg) directly after each microinjection.
Twenty minutes following the completion of both injections, animals were placed
in the operant box for completion of the extinction training sessions as described
above.

Histological Verification of Microinjection Sites
To obtain brain tissue for verification of cannula placement, rats were
anesthetized with isoflurane and euthanized by decapitation following previously
published methods (Gass et al. 2011). Following extraction, brains were placed
into 10% v/v formalin for at least 1 week at 4°C, transferred to a 30% (w/v) sucrose
solution for at least 72 hours at 4°C, and then immersed in 15% (w/v) sucrose for
at least 72 hours at 4°C. A cryostat (Leica CM1900, Leica Microsystems,
Bannockburn, IL) was used to section brains into 40-mm coronal slices and
mounted onto microscope slides. These slides were stained with cresyl violet for
histological verification of cannula placement using light microscopy.
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Determination of Estrous Cycle
A small pilot study was conducted in a separate group of animals (n =
6/group) to determine the impact of estrous cycle on fear extinction learning, since
these processes have been shown to be altered based on cycle phase (Milad et
al. 2009) To minimize any effects of the testing on behavioral outcomes, vaginal
swabs were completed at the end of each extinction session (Gass et al. 2007,
Ford et al. 2002, Roberts et al. 1998). This pilot experiment determined that there
were no changes in fear extinction learning between females at different phases
of the estrous cycle (Figure 3-2) and, thus, swabs were not completed on any
other groups within this study.

Statistical Analysis
Software including SPSS version 23.0 (SPSS Inc., Chicago, IL) and Prism
version 8 (GraphPad software, La Jolla, CA) were used to analyze the behavioral
data from these experiments. All tests required a p value of less than 0.05 for
69

statistical significance. Fear conditioning data was analyzed using independent
samples t-tests to compare the number of tone shock pairings needed to meet
criteria between males and females. Extinction behavior data were analyzed using
multiple two-way ANOVAs with Tukey’s multiple comparisons test performed
between each treatment group on each day of extinction to compare behavioral
responses to each individual conditioned stimulus presentation. An additional twoway ANOVA was completed to analyze overall freezing throughout extinction to
determine a main effect of treatment group on extinction learning. Animals were
removed from analysis once individual freezing was indicative of successful
extinction if it occurred prior to day five of extinction. Behavioral responses during
recall testing were analyzed using a one-way ANOVA with multiple comparisons
using Holm-Sidak post-hoc testing to determine differences in freezing between
multiple treatment groups.

Results
Experiment 1 used a total of 48 male and female animals to determine how
CIE exposure affects fear learning during extinction and how CDPPB treatment
impacts CIE induced deficits in fear extinction. The experimental groups consisted
of the following: Males and Females: Air+Vehicle vs. CIE+Vehicle vs. CIE+CDPPB
(n=8/group, 6 groups total).

70

Females meet fear conditioning criteria at a faster rate than males
All animals must first meet criteria for fear conditioning in order for further
analysis of fear extinction learning to be completed. All animals were freezing 80%
of the time in response to the tone regardless of subsequent CIE or air treatment
(Figure 3-4A), but females required significantly fewer tone/shock pairings to meet
this criteria when compared to males [t(14) = 9.431, p < 0.0001, n=16/sex] (Figure
3-4B). Although, while freezing rates differed between the sexes in the earlier
phases of conditioning, all animals were freezing at a similar rate by the end of
conditioning which allows for between group comparisons to be made during
extinction learning.
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CIE exposure resulted in moderate levels of intoxication for all animals
Following fear conditioning, animals were put into CIE exposure for a total
of two weeks. Throughout CIE, a 5-point behavioral intoxication rating scale (Nixon
and Crews 2002) was used to monitor the level of intoxication achieved following
each 14-hour ethanol exposure period. The goal for these experiments was a
behavioral intoxication rating of 2-3 which correspond to moderate levels of
intoxication. Throughout both Experiment 1 and Experiment 2, there were a total
of 80 male and female animals in CIE treatment groups and intoxication ratings
were averaged for all animals across exposure sessions. An overall average
intoxication rating of 2.2 ± 0.05 was achieved across all exposure periods and
animals. Blood ethanol concentrations were determined from tail vein puncture
directly following CIE exposure on days 2, 6, 10, and 15 to serve as a
complementary measure to the behavioral intoxication ratings. To achieve
moderate intoxication ratings, BEC target values were between 200 – 300 mg%.
Average BEC mg% values for males were recorded to be 249.6 ± 24.5 (Day 2),
240.3 ± 20.6 (Day 6), 230.2 ± 19.8 (Day 10), and 221.3 ± 29.54 (Day 15) with an
overall grand average across all 4 days of 235.4 ± 23.6. Females exhibited
average BEC mg% values of 259.2 ± 16.39 (Day 2), 279 ± 26.4 (Day 6), 251.9 ±
12.4 (Day 10), and 235.4 ± 18.57 (Day 15) with an overall grand average across
all 4 days of 256.4 ± 18.4 (Figure 3-3)
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Deficits in fear extinction learning are established following CIE exposure and are
treated with CDPPB
Following CIE exposure, animals were subjected to extinction training for a
total of five days. When examining the average freezing response on day of
extinction (Figure 3-5) there was a main effect of CIE on extinction learning such
that CIE exposed animals showed increased levels of freezing when compared to
air treated animals across the total duration of extinction training. Specifically,
males exposed to CIE exhibited significantly higher average rates of freezing to
the CS across multiple days of extinction training when compared to air-exposed
controls (Figure 3-5A) [F (49, 489) = 24.25, p < 0.0001, n=8/group]. The same
effect was observed in females as well, where animals exposed to CIE also
exhibited significantly higher rates of cue-induced freezing when compared to air
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exposed controls throughout extinction [F (49, 500) = 34.58, p < 0.0001,
n=8/group] (Figure 3-5B). Notably, treatment with CDPPB was effective at
attenuating CIE induced deficits in extinction through the facilitation of extinction
learning. There was a significant effect of CDPPB on extinction learning such that
CDPPB treatment reduced freezing during extinction in CIE exposed animals
across the entirety of extinction for both males [F(49, 481) = 30.58, p < 0.0001,
n=8/group] (Figure 3-5A) and females [F(49, 500) = 31.19, p < 0.0001, n=8/group)
(Figure 3-5B).
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CIE differentially affects extinction cue and context recall between the sexes
Two days following the completion of extinction training, animals were
tested for extinction cue recall through the presentation of a single tone in Context
B. A clear sex difference emerged during this test, since there was a significant
effect of CIE on cue recall in male, but not female, animals. Those exposed to CIE
prior to extinction exhibited an increased rate of freezing when compared to both
air exposed controls and CIE exposed male animals treated with CDPPB [F(2,21)
= 35.74, p < 0.0001, n = 8/group] (Figure 3-6A). This effect was not observed in
female animals, where those exposed to CIE did not differ in freezing behavior
from either air exposed controls or CDPPB treated animals [F(2,21) = 0.7977, p =
0.4636, n = 8/group] (Figure 3-6B).
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Following the extinction recall test, animals were placed back into the
original conditioning environment (context A) in the absence of any tone
presentation to assess freezing in response to the context only. Notably, all drug
manipulation occurred previously during extinction training, and all recall testing
was performed in a drug-free state. During this test, CIE-exposed male rats
showed a significant increase in context-induced freezing compared to both airexposed controls and CIE-exposed animals that were treated with CDPPB prior to
each extinction session [F(2,21) = 9.66, p = 0.001, n = 8/group] (Figure 3-7A).
Additionally, this treatment effect was observed in females as well, where there
was a significant increase in freezing to the context see in CIE treated animals
compared to air exposed controls and CIE+CDPPB animals [F(2,21) = 22.85, p <
0.0001, n = 8/group] (Figure 3-7B).
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CDPPB facilitates extinction learning through increases in mGlu5 activity in the
infralimbic cortex
The behavioral studies in Experiment 1 determined that CDPPB can
recover CIE induced deficits in fear extinction learning in both male and female
animals. Previous studies carried out in our lab using CDPPB found that the
enhancement of extinction of drug-seeking behaviors was associated with the
formation of calcium permeable AMPA receptors specifically in the IfL region of the
PFC (Gass et al. 2014). Therefore, in Experiment 2, we examined whether
CDPPB’s effects were dependent upon activation of mGlu5 receptors selectively
in the IfL cortex using the following treatment groups: Males and Females:
CIE+Vehicle

vs.

CIE+CDPPB

vs.

CIE+CDPPB+MTEP

in

the

IfL

vs.

CIE+CDPPB+MTEP in the PrL (n=6/group, 8 groups total).
During extinction, there was a significant main effect of treatment in male
rats where those administered CIE+CDPPB+MTEP exhibited freezing levels
similar to CIE animals that did not receive any treatment [F(49, 495) = 24.54, p <
0.0001, n=6/group] (Figure 3-8A). Essentially, microinjections of MTEP into the IfL
cortex concurrent with CDPPB treatment blocked its facilitating effects on
extinction learning. Additionally, a similar effect was observed in female animals
where local administration of MTEP into the IfL cortex just prior to systemic CDDPB
administration prevented the facilitating effects of CDPPB on fear extinction
learning, since CIE+CDPPB+MTEP treated animals exhibited increased levels of
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freezing when compared to CIE+CDPPB treated animals across multiple extinction
sessions [F(49, 495) = 24.67, p < 0.0001, n=6/group] (Figure 3-8B).

MTEP delivered into the IfL blocks the ability of CDPPB to prevent increases in
freezing during recall testing
During cue recall testing in context A, CIE+CDPPB animals that received
MTEP microinjected into the IfL exhibited increases in freezing behavior when
compared to CIE+CDPPB treated animals. MTEP treated animals also displayed
freezing similar to those exposed to CIE that did not receive CDPPB treatment
[F(2,15) = 27.62, p < 0.0001, n = 6/group] (Figure 3-9A). This data suggests that
when mGlu5 activity is blocked in the IfL so is CDPPB’s ability to prevent CIE
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induced increases in freezing during recall. Additionally, due to a lack of effect of
CIE on cue recall in female animals, and there were no differences observed
between female treatment groups [F(2,15) = 0.5237, p = 0.6028, n = 6/group]
(Figure 3-9B).

MTEP microinjections resulted in a similar effect on context recall in both
sexes. There was a significant effect of treatment on freezing during context recall,
since CDPPB treatment resulted in decreased freezing when compared to CIE
exposed animals, and MTEP treatment in these animals prevented the reduction
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in freezing to the context shown following CDPPB treatment in males [F(2,15) =
12.04, p = 0.0008, n =6/group] (Figure 3-10A) and females [F(2,15) = 17.16, p =
0.0001, n = 6/group] (Figure 3-10B). Essentially, CIE+CDPPB+MTEP treated
animals exhibited freezing similar to CIE+Vehicle animals, signifying a lack of
treatment effect of CDPPB when mGlu5 is blocked in the IfL. Additionally,
histological examination of the injection site demonstrated that all microinjections
were within the IfL cortex or its boundary regions (Figure 3-11).

80

Reduction of mGlu5 activity in the prelimbic cortex does not affect CDPPB’s ability
to reverse CIE induced deficits in extinction learning
Animals were exposed to the same fear conditioning and CIE model
followed by CDPPB treatment and MTEP administration during fear extinction, but
microinjections occurred in the PrL cortex. Following blockade of mGlu5 activity in
the PrL using MTEP, CDPPB treatment was still effective at attenuating CIEinduced deficits in extinction learning for both males [F(49,494) = 18.4, p < 0.0001,
n=6/group] (Figure 3-12A) and females F(49, 493) = 29.78, p < 0.0001, n=6/group]
(Figure 3-12B). Essentially, the ability of CDPPB to facilitate extinction learning
was not dependent on increases in mGlu5 in the PrL cortex.
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MTEP negative allosteric modulation of mGlu5 activity in the PrL did not affect CIE
induced increases in freezing during recall
In cue recall testing, CIE exposed animals exhibited a significantly
increased level of freezing when compared to CIE+CDPPB treated animals, and
MTEP treatment did not stop CDPPB from decreasing freezing during this session.
There was still a significant effect of treatment where CDPPB was still able to act
as an effective treatment on CIE induced heightened freezing during cue recall
[F(2,15) = 21.96, p < 0.0001, n = 6/group] (Figure 3-13A). Due to the lack of
change in freezing behavior as a result of CIE exposure in female animals, and
there were no differences in freezing between any of the treatment groups during
cue recall testing [F(2,15) = 1.196, p = 0.3296, n = 6/group] (Figure 3-13B).
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CIE treated animals also exhibited significantly higher rates of freezing to
the context when compared to those that received CIE+CDPPB and
CIE+CDPPB+MTEP treatment in males [F(2,15) = 12.7, p = 0.0006, n = 6/group]
(Figure 3-14A) and females [F(2,15) = 8.358, p = 0.0036, n = 6/group] (Figure 314B). This indicates that when mGlu5 is blocked in the PrL, CDPPB is still able to
work as a treatment to prevent heightened freezing in response to the context for
both sexes. Histological examination revealed that all microinjections were found
to be contained within the PrL cortex or its boundary regions (Figure 3-15).
Together, these findings indicate that mGlu5 activity in the IfL cortex, but not the
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PrL cortex, is required for CDPPB to attenuate deficits in fear extinction and recall
that result from chronic ethanol exposure.
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Discussion
These experiments indicate that stress exposure followed by chronic
ethanol intake leads to impairments in fear extinction and memory recall.
Additionally, these studies illustrate that the enhancement of mGlu5 activity in the
infralimbic cortex has the ability to reverse these CIE induced deficits in both
sexes. In CIE exposed animals, treatment with the mGlu5 positive allosteric
modulator, CDPPB, prior to each extinction training session was able to facilitate
extinction learning and prevent heightened freezing during cue and context recall.
We were able to determine that the IfL cortex is necessary for CDPPB’s effects on
extinction learning by microinjecting the mGlu5 negative allosteric modulator
MTEP in either the prelimbic or infralimbic cortex in combination with systemic
CDPPB administration, Further, sex differences were found with regards to initial
responses to fear stimuli during conditioning, as well as to extinction cue recall
testing. The current set of studies provide newly discovered beneficial effects of
CDPPB treatment on fear extinction and attenuation of heightened cue- and
context-induced freezing following chronic alcohol exposure.
When examining preclinical data there are always a number of limitations
that need to be addressed due to the complexity of modeling neuropsychiatric
disorders across species. First, examinations of estrous cycle were limited to a
small pilot study and were not completed for all animals included in these
experiments. Additionally, this pilot compared the behavior of animals starting in
metestrus/diestrus vs. proestrus/estrus instead of separating out all four phases
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into different groups. Regardless, due to the fact that the within group variability is
low and the rate of extinction is very similar between the groups, this provides initial
support that cycle phase is not altering extinction behavior. Further published
studies support these conclusions and determined that the rate of fear extinction
does not differ between females in proestrus vs. metestrus, and that females
administered estrogen prior to extinction displayed freezing behavior similar to
those that received vehicle (Maeng et al. 2015). While these studies did include a
wide variety of treatment groups, there were no animal cohorts that received only
CDPPB or MTEP in the absence of prior ethanol exposure. Previous work has
shown that CDPPB has the ability to enhance the extinction of ethanol seeking
behaviors during self-administration paradigms, so we would assume that the
cognitive enhancing effects would still be present when CDPPB treatment is
delivered without prior CIE exposure. Although published studies often focus on
the ability of CDPPB to enhance the extinction of drug seeking behaviors, it has
been reported that CDPPB can enhance fear extinction learning and recall (Sethna
and Wang 2014). While not included within this study, MTEP has been delivered
as a systemic treatment and has been found to have off target effects on behavior
(Simonyi et al. 2010; Pietraszek et al. 2005; Schulz et al. 2001). Alternatively, these
studies microinjected MTEP into select brain regions and, as such, negative
allosteric modulation of mGlu5 was restricted to these regions and the behavioral
effects that are observed when MTEP is administered systemically are not
expected to occur in these studies. An additional limitation in these studies comes
from the fact that a single dose of CDPPB and MTEP was used and a dose86

response curve was not examined. Due to the lab’s experience using these drugs,
multiple doses of CDPPB and MTEP have been tested to optimize CDPPB’s
effects on extinction learning and this dose-response curve has been previously
established (Gass and Olive 2009a; Gass and Olive 2009b; Gass et al. 2014; Gass
et al. 2017; Widholm et al. 2001; Cleva et al. 2011). When testing 0.3, 3, or 30
mg/kg CDPPB, 30 mg/kg CDPPB was necessary to induce significant effects on
extinction learning that were prevented with MTEP delivered intraperitoneally.
There were no effects on locomotor behavior or any changes in neurotoxicity when
CDPPB was administered at this dose (Gass and Olive 2009a). Additionally,
previous studies were completed that examined MTEP dosing and found that,
while 1 ug/uL was not sufficient to alter behavior and 10 ug/uL led to a reduction
in locomotor activity, the 3 ug/uL concentration was able to reduce ethanol seeking
without altering locomotor activity (Gass and Olive, 2009b). Therefore, the doses
of both CDPPB and MTEP used in these studies have been thoroughly validated
to have optimal effects on learning without causing deleterious side effects.
Taken together, the results from these experiments demonstrate multiple
behavioral deficits that occur as a result of stress and alcohol dependent
alterations in learning and memory due to impairments in infralimbic mGlu5
activity. These studies identify CDPPB as a pharmacological treatment that has
the potential to rescue alcohol induced deficits in learning and memory that could
be efficacious in treating these deficits often observed in the clinical PTSD/AUD
population. Additionally, the current findings identify potential brain mechanisms
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that underlie the detrimental effects of comorbid alcohol and stress exposure and
strongly support the therapeutic potential of the prefrontal glutamatergic system.
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CHAPTER 4

OPTOGENETIC MANIPULATION OF THE PRELIMBIC
CORTEX DURING FEAR MEMORY RECONSOLIDATION
ALTERS FEAR EXTINCTION IN A PRECLINICAL MODEL
OF CO-MORBID PTSD/AUD

Background and Significance

Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are
two highly debilitating psychology conditions that do not have many effective
treatment options. While there is a lifetime prevalence of 8.3% and 29.1% for
PTSD and AUD respectively, the presence of PTSD leads to a three times greater
chance of also developing AUD (Gilpin and Weiner 2017). As such, the rate of
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comorbidity between PTSD and AUD has been recorded to be as high as 30% 59% (Jacobsen et al. 2001). This is especially true for the military population,
where combat exposure was significantly associated with binge drinking behavior
and alcohol-related problems (Jacobson 2008), and alcohol has been established
as the most abused drug among veterans with PTSD (Gilpin and Weiner 2017).
Not only is there a higher lifetime prevalence of AUD in PTSD patients, but the
comorbid presence of these disorders causes more severe symptomology and
worse treatment outcomes (Neupane et al. 2017). For specific PTSD symptom
subtypes, including trauma reexperiencing and psychiatric distress, those using
alcohol reported a higher degree of symptom severity with poorer PTSD/AUD
treatment outcomes (Read et al. 2004). Interestingly, PTSD has a higher incidence
rate in female patients than male patients and there are sex-specific differences in
PTSD incidence, severity of symptoms, and propensity to use alcohol as a coping
strategy (Lehavot et al. 2014, Sonne et al. 2003). Since the prevalence of comorbid
PTSD and AUD is increasing and leads to worse symptomology and treatment
outcomes, there is increasing need for research into the underlying neurobiological
processes that are related to the establishment and maintenance of these
disorders. Further, these established sex-differences in the clinical population
make it increasingly important to conduct preclinical studies in both male and
female animals to determine optimal treatment strategies between the sexes.
The establishment and treatment of both PTSD and AUD rely on learning
and memory systems that overlap in the prefrontal cortex (PFC). There have been
both functional and structural alterations observed in the infralimbic (IfL) and
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prelimbic (PrL) regions of the medial PFC (mPFC) in patients with PTSD and AUD
(Gilpin and Weiner 2017). Additionally, these regions have important functions in
the promotion and suppression of fear and drug seeking behaviors (Peters et al.
2009). Importantly, the most common psychological treatment strategies for PTSD
and AUD rely on intact mPFC processes, and impaired functionality of these areas
might explain why these treatments do not have a high rate of efficacy (Conklin et
al. 2002). Specifically, one common method of AUD and PTSD treatment involves
exposure therapy, where exposure to trauma or drug related cues occurs in a safe
and controlled environment to allow the patient to form new associations between
these cues and their conditioned responses (Watkins et al. 2018). This treatment
method involves many facets of learning and memory systems that rely on the PFC
including memory reconsolidation and extinction (Cooper et al. 2017). Memory
reconsolidation is a process that allows memories that have already been
consolidated into long-term storage to be retrieved and updated with new
information (Nader et al. 2015). This is also important for extinction learning during
which new associations are formed between previously established cues and
responses (Quirk et al. 2008). While these learning and memory processes are
required for PTSD and AUD treatments to be effective, clinical and preclinical data
have found them to be impaired following exposure to alcohol (Bisby et al. 2015,
Kroener et al. 2012, Smiley et al. 2020). As such, a novel line of research has
emerged that focuses on targeting these learning and memory processes with
pharmaceutical treatments to enhance the effectiveness of the extinction learning
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reliant therapies used to treat PTSD and AUD (McGuire et al. 2014; Gass et al.
2014b).
Our lab has recently established that both male and female animals
exposed to chronic binge-like levels of ethanol exhibit deficits in the ability to
extinguish fear cue associations during extinction learning. We also determined
that this process was dependent on glutamatergic activity at metabotropic
glutamate receptor 5 (mGlu5) receptors specifically in the IfL region of the mPFC
(Smiley et al. 2020). The current set of experiments was designed to further
examine the relationship between alcohol exposure and fear related learning and
memory and the involvement of the PrL and IfL subregions. Rats were first
exposed to fear conditioning followed by chronic intermittent ethanol exposure
(CIE) to model the clinical pattern of trauma exposure followed by binge ethanol
intake. Optogenetics was then used to manipulate the prelimbic and infralimbic
regions of the mPFC during fear memory reconsolidation to test the hypothesis
that blockade of PrL fear promotion during fear memory reconsolidation would lead
to a decrease in the presentation of fear behaviors during extinction. These data
provide important information regarding the role of the mPFC in fear learning and
memory that is impaired following exposure to chronic ethanol and support the
involvement of these regions in the treatment of comorbid PTSD and AUD.
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Materials and Methods

Animals
Wistar rats (48 male, 48 female, postnatal day 55 on delivery, Charles River
Laboratories) were pair housed in standard polycarbonate cages with food and
water continuously available except for during behavioral testing. Prior to
experimental manipulation, animals were habituated to a 12:12 reverse light-dark
cycle. All behavioral testing was then performed during the dark phase of the cycle.
Approval by the Institutional Animal Care and Use Committee at the Medical
University of South Carolina was achieved for all experimental testing under the
guidelines of the National Research Council’s Guideline for the Care and Use of
Mammals in Neuroscience and Behavioral Research (2003). A total of 96 animals
were used for these studies and were assigned to the following treatment groups
outlined in Table 4-1.
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Surgical Procedures
Experiments followed the overall design and timeline presented in Figure
4-1. For all surgical procedures, rats were anesthetized with isoflurane and oxygen
at a flow rate of 0.4 L/min and placed in a stereotaxic device (Kopf Instruments).
For Experiment 1, animals received a unilateral injection either 0.5 uL of pAAVCaMKIIa-eNpHR3.0-eYFP or an EYFP reporter construct (UNC Viral Vector Core,
Chapel Hill, NC) injected at a rate of 0.1 uL per minute in to the prelimbic cortex
(PrL). The stereotaxic coordinates used for the PrL were as follows:
anterior/posterior + 3.24, medial/lateral ± 0.6, and dorsal/ventral -2.2 (in millimeters
from bregma and the skull surface). Experiment 2 followed the same procedure,
but virus was instead injected in the IfL at the following coordinates:
anterior/posterior +3.24, medial/lateral ± 0.6, and dorsal ventral -3.8 (in millimeters
from bregma and the skull surface). For all surgeries, the injection needle
(Hamilton, 1 uL syringe) was mounted in a micro-infusion pump (Harvard
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Apparatus) and kept in place for 10 minutes following the injection to allow for virus
diffusion. The fiber optic implant (Thorlabs Inc., Newton, NJ) was then placed
directly dorsal to the virus injection site and stainless-steel screws covered in
dental cement were used to secure the implant to the skull. The wound was sutured
with 3-0 Nylon sutures and treated with 2% triple antibiotic ointment. Rats were
post-operatively treated with antibiotics (cefazolin, 0.3 mL, s.c.) and carprofen
analgesic (0.4 mL, s.c.) for three days following the surgery. Following the
completion of all behavioral procedures, rats were perfused with 0.9% saline
followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer. Following
extraction, brains were kept in 4% PFA for 48 hours before being transferred to
20% sucrose for an additional 72 hours. Brains were frozen and coronal slices
were sectioned at 40 um and examined for fluorescence to histologically verify
virus and fiber placement.

Fear Conditioning Paradigm
All behavioral testing was performed in standard operant boxes (Med
Associates Inc., Fairfax, VT) contained within sound attenuating chambers.
Auditory fear conditioning procedures began nine days after surgery to allow for
recovery. Animals were operantly conditioned using four pairings of a tone
(conditioned stimulus [CS] - 30 sec, 80 dB, 3 kHz) with a 0.75 mA foot-shock that
occurred during the last two seconds of the tone. A 60 second habituation period
occurred at the start of each session, and each tone/shock pairing was separated
by a ten second inter-stimulus interval. This conditioning protocol was repeated for
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a total of three days until all animals achieved conditioning criteria of freezing for
80% of tone. Freezing during each session was digitally determined by
FreezeScan (CleverSys Inc., Reston, VA) (Milad and Quirk 2012, Sierra-Mercado
et al. 2011, Quirk and Mueller 2008, Quirk et al. 2010). This protocol has been
used by our lab (Smiley et al. 2020, Gass et al. 2014a, b, Gass et al. 2017, Gass
and Olive 2009) and others (Singewald et al. 2014, Singewald and Holmes 2019,
VanElzakker et al. 2013) as a preclinical model of stress exposure used to evaluate
fear learning and memory (Cain et al. 2012, VanElzakker et al. 2013).

Chronic Intermittent Ethanol Procedure
Once fear conditioning criteria was met, animals were exposed to a twoweek chronic intermittent ethanol (CIE) protocol. CIE chambers consisted of clear
acrylic boxes that measured 24 × 24 × 14 inches (Plas Labs; Lansing, MI), and
pair-housed cage mates were placed in the same chamber for a total of 15 nights
from 1800 hours in the evening until 0800 hours the next morning. This schedule
resulted in a total of 14 hours of vapor exposure and 10 hours of abstinence each
day. A five-point behavioral scale was used to monitor individual levels of
intoxication for each animal. Briefly, motor impairment was assigned a rating based
on the following behaviors: 1 - no signs of intoxication, 2 - slightly intoxicated (slight
motor impairment), 3 - moderately intoxicated (obvious motor impairment but able
to walk), 4 -highly intoxicated (dragging abdomen, loss of righting reflex), 5 extremely intoxicated (loss of righting reflex and loss of eye blink reflex) (Nixon and
Crews, 2002). The goal of each exposure session was to achieve moderate
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intoxication with a behavioral rating of 2-3, and this level of intoxication has been
consistently shown in our lab to correspond to ~200-300 mg/dl blood ethanol
concentration (BEC) (Smiley et al. 2020, Trantham-Davidson et al. 2014, Gass et
al. 2014a, Gass et al. 2017, Uys et al. 2016). Body weight was monitored
throughout this procedure to maintain the health of the animals. Additionally,
control animals were treated similarly by bringing them into the lab and placing
them outside of the chambers throughout exposure.

Memory Reactivation and Optogenetic Stimulation Parameters
Two days following the end of CIE, animals were exposed to fear memory
recall paired with optogenetic inhibition of the PrL or IfL to block fear memory
reconsolidation. Fear memories were reactivated through the presentation of the
conditioned fear cues including the fear environment as well as the tone that
previously served as the conditioned stimulus. Animals received optogenetic
inhibition during the memory reconsolidation period in their home cage
immediately following the presentation of the fear associated cues. Photoactivation
was induced by 532 nm light delivered intracranially for three minutes (10 Hz
pulses, 15 ms pulse duration, 10 mW illumination).

Fear Extinction and Spontaneous Recovery
Following this initial fear memory reactivation, animals completed a total of
five extinction sessions to monitor freezing behavior in response to the CS to
determine the effect of optogenetic inhibition of the PrL or IfL cortex during memory
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reconsolidation on extinction learning. All extinction sessions consisted of ten
presentations of the tone (CS) for thirty seconds separated by a 10 second interstimulus interval. There was no shock delivered during these sessions, and
freezing was recorded during each tone presentation. Extinction criteria was met
when animals were freezing less than 30% of the time in response to the CS. Once
animals successfully met this criterion, there was a three-week break before they
were placed back into the operant boxes for a single session during which the CS
was presented a single time and freezing was measured for the duration of the
tone (30 seconds) to measure the spontaneous recovery of fear behaviors.
Importantly, optogenetic inhibition was only administered following the initial fear
memory reactivation, and all extinction and recall testing was completed without
any photostimulation.

Statistical Analyses
The primary dependent variable measured for the fear conditioning,
extinction, and spontaneous recovery sessions was percent freezing in response
to the conditioned stimulus (tone). These behavioral data were analyzed using
SPSS version 23.0 software (SPSS Inc., Chicago, IL) and Prism version 8
(GraphPad software, La Jolla, CA). Both fear conditioning and extinction data were
analyzed using a 2-way ANOVA with Holm-Sidak multiple comparisons as the
post-hoc test used to determine differences between each treatment group.
Extinction data were analyzed as an average response to all ten CS presentations
for each day of extinction. For spontaneous recovery data, an ordinary one-way
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ANOVA with Holm-Sidak multiple comparisons test used to compare all four
treatment groups. All experiments used an n of 6 animals/treatment group, and a
p value of less than 0.05 was considered statistically significant.

Results

These experiments used chronic intermittent ethanol exposure to model
alcohol dependence with binge-like levels of ethanol exposure. This highly
characterized model has been previously used by our lab to establish deficits in
fear- and drug-related learning (Smiley et al. 2020; Gass et al. 2017). A five-point
behavioral intoxication scale (Nixon and Crews 2002) was used to gauge
intoxication levels in each of the animals with a target of moderate intoxication
corresponding to a 2-3 rating. A subset of 72 (36M, 36F) out of the total 96 animals
underwent CIE exposure, and the intoxication ratings were averaged between
each sex and across all exposure periods. The intoxication score average across
all days and all rats was 2.8 ± 0.09. As a complementary measure to the behavioral
intoxication rating, blood ethanol content (BECs) was obtained from tail vein
puncture following exposure periods on days 2, 6, 10, and 15. The target range for
BEC was between 200 – 300 mg%, and our analysis revealed average BEC mg%
values for males of 267.36 ± 29.17 (Day 2), 262.4 ± 27.21 (Day 6), 251.8 ± 26.3
(Day 10), and 239.54 ± 24.6 (Day 15) with an overall grand average across all 4
days of 255.3 ± 26.82. For the females, our analysis revealed average BEC mg%
values of 261.7 ± 25.45 (Day 2), 265.5 ± 28.76 (Day 6), 257.11 ± 22.52 (Day 10),
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and 242.08 ± 19.73 (Day 15) with an overall grand average across all 4 days of
256.6 ± 24.1 (Figure 4-2).

Prelimbic inhibition during fear cue memory reconsolidation facilitates extinction
learning
In Experiment 1, we examined the effect of PrL inhibition during fear
memory reconsolidation on fear extinction learning in a rat model of PTSD/AUD.
Experimental procedures were completed following the outline in Figure 4-1. The
treatment groups used for Experiment 1 included comparisons between animals
that received CIE without PrL Inhibition (CIE-NI), CIE with PrL Inhibition (CIE-I),
CIE without a surgical implant (CIE), and air (Air) for each sex.
Prior to extinction testing, all animals were required to meet a criteria of
freezing 80% of the time in response to the tone (conditioned stimulus, CS) during
the fear conditioning phase. Analysis of freezing behavior during this phase of
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training was completed to ensure that all animals received the same degree of fear
conditioning before subsequent experimental manipulation. In Figure 4-3, each
data point represents an average of the freezing responses to the four CS
presentations that occur on each day of conditioning. For male animals, there was
a significant difference in freezing to the CS between treatment groups during the
initial CS presentations (Figure 4-3A, F(3, 20) = 14.94, p < 0.0001), but there were
no significant differences between the groups by Day 3 (F(3, 20) = 0.8281, p =
0.4939), and all animals met the 80% criteria. For females, there was no significant
difference in freezing behavior throughout conditioning between any treatment
groups (Figure 4-3B, F(3, 60) = 1.998, p = 0.1239), and all animals were freezing
over 80% by their third conditioning session.
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Animals were permitted a two-day break to allow for fear memory
consolidation after conditioning, and were subsequently exposed to two weeks of
CIE. The following week, animals were put back into the fear context and exposed
to a single presentation of the CS (tone) to induce fear memory recall. Freezing
was measured during this fear recall session and analysis revealed no differences
between any groups in baseline freezing during this session (Figure 4-4).
Immediately following the fear memory recall session, optogenetic inhibition of the
PrL occurred during the memory reconsolidation phase and freezing to the CS was
measured across five subsequent extinction sessions. Each bar depicted on
Figure 4-4 is representative of average freezing to a total of 10 tone presentations
on each extinction day. For male animals there was a main effect of treatment on
freezing to the CS throughout extinction (Figure 4-4A, F (3, 120) = 25.83, p <
0.0001). As shown in Figure 4-4A, CIE exposed animals that did not receive
surgical implants exhibited significantly higher levels of freezing when compared
to air exposed animals throughout extinction which replicates our recently
published studies regarding CIE’s effects on extinction learning (Smiley et al.
2020). Additionally, these experiments found that inhibition of the PrL during fear
memory reconsolidation prevented CIE induced deficits in extinction learning,
since CIE-I animals exhibited significantly lower levels of freezing when compared
to the CIE-NI and CIE groups. This was also observed in female animals where
there was a main effect of treatment on freezing in response to the tone throughout
extinction training (Figure 4-4B, F (3,120) = 21, p < 0.0001). In these animals, CIE
exposure led to deficits in extinction learning with CIE exposed animals exhibiting
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higher levels of freezing to the CS compared to air exposed animals throughout
extinction. Furthermore, these experiments found that blockade of PrL activity
during fear memory reconsolidation had the ability to enhance extinction since CIEI animals exhibited significantly lower rates of freezing when compared to CIE-NI
and CIE animals on multiple days of extinction training. Individual differences
between all treatment groups on each extinction day are shown in Figure 4-4
where * = CIE-I vs. CIE and CIE-NI, and + = Air vs. CIE.

Following extinction, animals were permitted a three-week break before
being tested for spontaneous recovery of fear behavior in response to the fear
context and a single CS (tone) presentation. Blockade of fear memory
reconsolidation, through inhibition of the PrL cortex during the initial fear memory
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recall session, prevented the spontaneous recovery of freezing behavior in male
and female animals, which supports the hypothesis that PrL inhibition disrupted
fear memory reconsolidation. There was a main effect of treatment for males (F
(3, 20) = 8.594, p = 0.0007) where CIE exposed animals exhibited heightened
freezing when compared to air exposed controls, and CIE-I animals froze
significantly less than the CIE-NI group (Figure 4-5A). This was also observed in
females, where CIE and CIE-NI exposed animals exhibited a significantly higher
rate of freezing when compared to air exposed controls and the CIE-I group
(Figure 4-5B, F (3, 20) = 8.493, p = 0.0008). Essentially, manipulation of fear
memory reconsolidation through inhibition of the PrL had long term effects on fear
behaviors elicited in response to previously conditioned fear cues. Individual
differences between the groups are noted on Figure 4-5 where * = CIE-NI vs. CIEI and + = CIE vs. Air.
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Infralimbic inhibition following fear cue exposure does not alter extinction learning
For Experiment 2 we used the same methodology described above, but
optogenetic inhibition was instead targeted to the IfL cortex. The treatment groups
used for Experiment 2 included animals that received CIE without IfL Inhibition
(CIE-NI), CIE and IfL Inhibition (CIE-I), CIE without a surgical implant (CIE), and
air (Air) for each sex. Prior to any experimental manipulation, freezing behavior
during fear conditioning was examined to confirm that the responses to fear stimuli
were consistent between treatment groups. For male animals, on Day 1 of
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conditioning, there were significant differences between animals who would
subsequently receive different treatments (F (3, 20) = 6.085, p = 0.0041), but by
Day 3 of conditioning all animals met freezing criteria of 80% and there were no
differences between any treatment groups (Figure 4-6A, F (3, 20) = 1.414, p =
0.2680). This trend was similar in female groups, where on Day 1 there were
significant differences between the groups (F (3, 20) = 4.870, p = 0.0106), but by
Day 3 there were no differences between any groups and all animals were freezing
above criteria of 80% (Figure 4-6B, F (3, 20) = 0.6780, p = 0.5757).
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Once all animals successfully met conditioning criteria and completed CIE
exposure, they were re-exposed to the fear associated environment and cues to
induce fear memory recall. Directly after this session, the IfL was inhibited during
the memory reconsolidation phase and animals were subsequently exposed to five
extinction training sessions during which freezing to the CS was recorded. A main
affect was observed with regards to treatment in male animals (Figure 4-7A, F (3,
120) = 11.53, p < 0.0001), but an analysis of multiple comparisons revealed that
this treatment effect was specific to CIE animals who exhibited heightened freezing
when compared to the air group throughout extinction training. Unlike PrL inhibition
groups, there were no significant differences recorded in freezing throughout
extinction when comparing the CIE-I and CIE-NI groups. This effect was also
absent in female animals, where there was a significant impact of CIE exposure (F
(3, 120) = 5.249, p = 0.0019), but there were no significant differences between
the CIE-I and CIE-NI groups (Figure 4-7B). Essentially, while inhibition of the PrL
during fear memory reconsolidation was able to prevent CIE induced deficits in
extinction learning, IfL inhibition during fear memory recall in CIE exposed animals
did not alter freezing behavior.
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Following extinction, animals were permitted a three-week break before
being tested for the spontaneous recovery of freezing behavior following exposure
to the fear-related cues and context. For male animals, there was a significant
effect of treatment (Figure 4-8A, F (3, 20) = 3.573, p = 0.0323), but multiple
comparisons analysis revealed that the only significant difference was between the
CIE and Air groups (p = 0.0258). Importantly, there was no difference in freezing
to the CS between the CIE-I group and the CIE-NI group. Additionally, for female
animals, there were no significant differences between any treatment groups in
freezing to the CS during the spontaneous recovery testing session (Figure 4-8B,
F (3, 20) = 0.9874, p = 0.4187). Following the completion of the behavioral
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experiments, animals were transcardially perfused and brains were collected for
analysis of virus placement (Figure 4-9).
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Discussion
These studies conclude that inhibition of the PrL following fear memory
recall blocks fear memory reconsolidation and, thus, facilitate the extinction of fear
behaviors and reduce freezing during spontaneous recovery. This was shown to
be observed in both male and female animals and was specific to the PrL cortex
since repetition of the experiment targeting the IfL cortex instead did not induce
the same behavioral response. The rodent model of comorbid PTSD/AUD used in
these studies also served to replicate and confirm previous studies completed in
our lab that explored deficits in fear learning following binge-like ethanol exposure
(Smiley et al. 2020). These experiments provide preclinical evidence that
alterations of activity in the prelimbic cortex can serve to alter the presentation of
fear behaviors during extinction learning and spontaneous recovery in both males
and females. Additionally, these studies support the hypothesis that manipulation
of signaling in these regions could serve as a viable treatment option for individuals
with PTSD/AUD.
Previously, work in our lab has thoroughly investigated the role of the PrL
and IfL cortices in the expression and suppression of alcohol seeking behavior
(LaCrosse et al. 2015, Gass et al. 2014a, b, Gass et al. 2017, Gass et al. 2013).
Briefly, these studies focused on positive allosteric modulation of the PrL and IfL
cortices to treat the structural and functional deficits that occur as a result of chronic
alcohol exposure. These experiments also examined the behavioral impairments
that can occur as a result of chronic ethanol, including impaired extinction of drugseeking behaviors induced by plasticity changes in these regions. Due to the
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additional function of the PrL and IfL in the expression and suppression of fearrelated behaviors (Hayen et al. 2014, Goode et al. 2019, Peters et al. 2009,
Moorman et al. 2015, Palombo et al. 2017), current work has focused on
manipulation of these regions to treat co-occurring PTSD and AUD. For these
experiments, animals are exposed to fear conditioning paradigms before CIE
exposure to translationally model the progression of these comorbid disorders.
Essentially, this design allowed us to model the human pattern of trauma exposure
followed by binge-like levels of ethanol used to self-medicate anxiety symptoms
while fear extinction training modeled the exposure-type therapies used in human
psychiatric treatment for PTSD/AUD. Recently, we demonstrated the ability of
chronic alcohol exposure to cause deficits in fear extinction learning and used
glutamatergic manipulation of IfL during fear extinction to treat these deficits
(Smiley et al. 2020). The present experiments expanded upon these data by using
optogenetics to manipulate prefrontal glutamatergic activity during fear memory
recall to affect extinction learning instead of during active extinction learning.
These results add to the established literature regarding differential roles for the
PrL and IfL cortices and incorporate a novel aspect by using a comorbid model of
PTSD/AUD in both male and female animals.
While clinical examinations of PTSD rely on a variety of symptoms that are
verbally described, such as re-experiencing the trauma, nightmares, and intrusive
thoughts, we cannot rely on these same diagnostic criteria in animal models (Miao
et al. 2018). As such, using a preclinical model introduces a variety of limitations
that need to be addressed. To utilize a valid model of PTSD, we have to rely on
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the underlying neural circuitry that is involved in fear behaviors, behavioral
responses that are shared between humans and rodents, and the establishment
of the disorder through exposure to a fixed experience of extreme stress
(Flandreau et al. 2017). With regard to specific preclinical PTSD models, the model
must allow for longitudinal studies of symptomology to assess long term responses
to fear stimuli, be induced by exposure to an aversive event with only a short
duration necessary to invoke PTSD-like symptoms, and increasing intensity of the
stimulus must be able to increase the severity of the outcomes (Siegmund and
Wotjack 2006). Established preclinical models of PTSD include restraint stress,
single prolonged stress, social defeat stress, and fear conditioning. While each of
these models has aspects that meet the above criteria, fear conditioning is the
model that best allows us to answer questions regarding longitudinal relationships
between the alcohol exposure and fear related learning and memory (Ursano et
al. 2007, Borghans et al. 2015, Lissek et al. 2015, Singewald et al. 2019, Mahan
et al. 2012, Amstadter et al. 2009). While our preclinical model of PTSD/AUD
achieves validity, there are additional limitations that need to be considered when
examining these data. First, all extinction training was completed relatively close
to the completion of ethanol exposure. The literature regarding the effects of
ethanol on fear learning have been mixed with regards to both the level of ethanol
exposure that is required to induce changes in fear learning as well as any longterm effects induced by ethanol (Holmes et al. 2012, Quiñones-Laracuente et al.
2015). As such, an important aspect of future studies would be to include groups
that receive extinction training at a later date to assess the long-term effects of
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ethanol exposure on fear learning. An additional limitation comes from the fact that
estrous cycle was not examined in the female treatment groups. While estrous
cycle has been shown to alter behavior in certain preclinical models of addiction
(Lacy et al. 2016, Anker and Carroll 2011) and cognition (Cordeira et al. 2018,
Broestl et al. 2018), data from both our lab (Smiley et al. 2020) and others (Maeng
et al. 2015) establishes the fact that estrous cycle phase does not have an effect
on freezing behavior during extinction. Therefore, we do not see estrous cycle as
a factor that could serve to alter fear behaviors during extinction in these studies.
Taken together, the results from these experiments conclude that inhibition
of the PrL, and not the IfL, during fear memory reconsolidation facilitates extinction
learning and prevents increased freezing during memory reconsolidation for both
male and female animals in a preclinical model of PTSD/AUD. These studies
support the use of modulation of memory reconsolidation for the treatment of
learning and memory deficits that occur as a result of exposure to stress and
chronic alcohol and, further, identify specific time-points and brain regions that are
necessary for this treatment effect.
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CHAPTER 5

ADOLESCENT THC AND ETHANOL EXPOSURE LEADS
TO IMPAIRMENTS IN PREFRONTAL CORTEX RELIANT
COGNITION

Background and Significance
Cannabis use disorder (CUD) has doubled in prevalence over the past
decade as marijuana becomes increasingly accessible due to a country-wide trend
towards legalization. As a result, marijuana is the most commonly used illicit drug
in the United States. Importantly, levels of Δ-9-tetrahydrocannabinol (THC), the
psychoactive component of the drug, have also steadily increased in recent years.
Studies have found that cannabis use has grown the most in the adolescent
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population, a group that is increasingly at risk for harmful side-effects of drug use
due to ongoing brain maturation, most notably in the prefrontal cortex (PFC). This
region is involved in both addiction and anxiety disorders that can result from
neurochemical changes due to trauma experience or insults from chronic drug use.
These alterations often lead to cognitive deficits that maintain and reinforce both
disorders. Clinical studies have found that the age of onset of marijuana use is
positively correlated with the development of both CUD as well as long-term
impairments in cognition. The main deficits examined in this patient population
include behavioral inflexibility and propensity towards both risky and impulsive
behaviors. These deficits are common to both substance use disorders and anxiety
disorders and serve as barriers to successful treatment outcomes. Increasing
evidence indicates that CUD often occurs along with other debilitating conditions
including both alcohol use disorder (AUD) and anxiety disorders such posttraumatic stress disorder (PTSD). These disorders have also been shown to
induce similar cognitive deficits that could add to the deleterious effects of chronic
cannabis exposure. The average age at which CUD develops is around late
adolescence to early adulthood, a period in which brain development, especially
in prefrontal regions, is still progressing (Khoury et al. 2010). Surveys of high
school seniors determined that half of them have tried marijuana while 5% of them
participate in daily use (Schweinsburg et al. 2008). Adolescents who begin
marijuana use earlier, and adult users who started use in mid-adolescence, have
more problems with cognition even following the cessation of marijuana use.
Studies completed in both animals and humans indicate that chronic marijuana
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exposure causes a greater vulnerability to developing abnormalities in cognition
(Schweinsburg et al. 2008, Pope et al. 2003, Patton et al. 2002, Irimia et al. 2015,
Hill et al. 2006). There is consensus in the literature that, when comparing early
vs. late onset cannabis use, those that started using cannabis earlier in life during
adolescence exhibit poorer cognitive performance than those that started using
cannabis later and those that did not use cannabis (Pope et al. 2003). Interestingly,
there has also been associations found between long term cannabis use and
higher rates of developing anxiety and depression later in life, especially for
females who begin drug use in adolescence (Patton et al. 2002). While the acute
effects of cannabis use on cognition are established, there is less data that
examines long term effects on cognitive processing. Studies using animal models
are also scarce, but there is some evidence that long term exposure to THC can
cause motor impulsivity and perseveration, hallmarks of behavioral disinhibition
and impaired cognitive flexibility (Irimia et al. 2015). Other models that have used
CB1 agonists have found decreased behavioral flexibility in a model of strategy set
shifting (Hill et al. 2006). While the presence of cognitive deficits is being explored
in the clinical population, there is further research needed to determine the
mechanism by which these deficits are induced to develop new targets for
pharmacological treatments. Therefore, these studies examined the impact of THC
vapor exposure and chronic intermittent ethanol exposure (CIE) as a model of cooccurring cannabis and alcohol use during adolescence on prefrontal cortex reliant
behaviors. Following adolescent exposure to THC/ethanol, animals were tested for
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deficits in cognition and alterations in fear and alcohol seeking behaviors were
addressed with the use of N-acetylcysteine as a pharmaceutical treatment.

Materials and Methods
Animals
Male Wistar rats were postnatal day (PD) 35 for adolescents and PD 55 for
adults upon arrival (Charles River Laboratories) and were pair housed in standard
cages in a vivarium that maintained a reverse light-dark cycle. Lights were turned
off at 0900 and this allowed for behavioral testing to occur during the dark phase.
Animals received continuous access to food and water except during behavioral
testing which occurred for up to one hour per day. All experiments had prior
approval by the Institutional Animal Care and Use Committee at the Medical
University of South Carolina and were completed within guidelines set forth by the
National Research Council’s Guideline for the Care and Use of Mammals in
Neuroscience and Behavioral Research (2003). A total of 88 animals were used
across Experiments 1 and 2, and the treatment groups were assigned based on
the outline in Table 5-1.
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Adolescent THC Vapor Exposure
THC vapor exposure started at PD 40 for adolescent animals and PD 60
for adults. The method of vapor administration occurred according the protocol
previously established by Spencer et. al. 2018. During each exposure session,
animals received a total of 20 minutes of vapor exposure per day for 5 days. Out
of the total 20 minutes, each THC exposure session is broken up in the following
manner to keep THC concentrations steady: in the morning there were two 5minute exposures followed by a three-hour break and two additional 5-minute
exposures. The solution vaporized during each exposure session consisted of
THC at a concentration of 200 mg per mL of ethanol and CBD at 20 mg per mL of
ethanol. These solutions are mixed at a 1:1:1 ratio with glycerol to obtain a final
solution containing THC and CBD at a ratio of 10:1. A Volcano (Storz and Bickel,
Oakland, CA) was used to vaporize 150 uL of the THC/CBD solution and the
resulting vapor was administered equally among the animals. Animals assigned to
the NAC treatment groups received an intraperitoneal (IP) injection of the drug
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immediately following each exposure session. Following the five total days of THC
exposure, animals were permitted a two-day break before entering chronic
intermittent ethanol exposure (CIE).

Chronic Intermittent Ethanol Exposure (CIE)
Chronic intermittent ethanol exposure (CIE) is a model of binge-like alcohol
consumption that uses repeated cycles of ethanol vapor exposure and abstinence.
This procedure started at ~PD 47 for animals in Experiment 1 and consisted of
four nights of vapor exposure from 1800-0800 (14 hours on/10 hours off) followed
by a two-day break, and this cycle was completed a total of two times. Intoxication
levels were graded on a five-point scale that judges the level of intoxication based
on motor behavior. Rats were scored based on the following behaviors: 1: no signs
of intoxication and no motor impairment, 2: slight intoxication and slight motor
impairment, 3: moderate intoxication with obvious motor impairment but retains the
ability to walk, 4: loss of righting reflex, highly intoxicated, 5: loss of righting reflex
and eye blink reflex, extremely intoxicated (Nixon and Crews, 2002). The goal of
each CIE session was to reach moderate intoxication levels which corresponds to
a 2-3 on the five-point scale and ~250 mg/dl BEC. Animals in treatment groups
that received NAC received injections two hours before going into the CIE
chambers at night and immediately after they came out of the chambers in the
morning.
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Strategy Set-Shifting Task
To study the effect of adolescent THC and ethanol exposure on behavioral
flexibility in adulthood, Experiment 1 utilized a strategy set-shifting paradigm
following the techniques established by Stan Floresco (Floresco et al. 2008). To
establish lever pressing behavior, there were a total of five training phases prior to
the set-shifting test. First, Phase1A consisted of both levers being presented and
a press on either lever would result in the delivery of 10% sucrose. Once all
animals were able to perform ~50 lever presses within this 30-minute session, they
were able to move onto Phase1B (~10 days of training). This phase was identical
to Phase 1A with the addition of retraction of the levers following each lever press.
Again, animals had to maintain ~50 lever presses during these session before
moving on the Phase1C (~8 days of training). Phase1C built upon 1B by presenting
the retractable levers for ten second intervals. If animals did not press the lever
within the ten seconds, levers were retracted, and the trial restarted. Animals were
able to move on from Phase1C once they finished the session with less than 10
omissions (~10 trials). Animals were then tested for a side preference for the test
session to be completed using the opposite lever. The following two phases
involved pressing a specific lever according to a trained rule to determine changes
in cognitive flexibly when the rule was changed between sessions. Rule 1 was
established in PhaseCue, during which animals were required to respond to the
lever that was cued by illumination of the associated stimulus light. Criteria for
learning this rule was met when all animals press 8 times in a row correctly in a
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minimum of 30 trials. These experiments tested a between-session set-shift, so,
once criteria was met for the first rule, the session on the following day was under
a second rule. The second rule required the animals to press on a single lever
location regardless of where the light appears. Two days of testing were
administered using this criteria, and animals were eliminated from the experiment
if they did not meet criteria within this time period. Two different types of errors,
perseverative and regressive, were recorded to determine if the ability to either
shift to new strategy or maintain the new strategy was affected by drug exposure.
Perseverative errors were those that occur before the animal has made five correct
presses under the second rule while regressive errors are those that occur after
five correct presses have been made. Animals that take longer to learn the second
rule and make more errors that cause them to continue responding for the original
rule are those considered to have impaired behavioral flexibility.

Operant Ethanol Self-Administration
For Experiment 2, operant self-administration paradigms were used to
determine the effects of adolescent THC exposure on ethanol seeking during
adulthood. Following THC exposure, animals were placed into operant chambers
and trained to lever press for 20% ethanol on an FR-1 schedule of reinforcement.
These self-administration sessions each lasted one hour and occurred three days
a week. Each lever press on the active lever delivered 20% ethanol v/v in water
accompanied by stimulus light illumination and tone presentation (2900 Hz, 65 dB)
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and was followed by a 4-second timeout period during which presses were
recorded but did not lead to reinforcer delivery. Once response criteria of 30 lever
presses was met (~10 sessions), ethanol concentration was lowered to 10% and
criteria of 60 lever presses was met (~15 sessions). Animals completed extinction
training following the completion of self-administration. During extinction sessions,
pressing on the active lever allowed for stimulus light illumination and tone
presentation in the absence of any ethanol reinforcer. Extinction criteria was met
when lever pressing for each rat was reduced to 80% of the lever presses recorded
on last two days of self-administration training (~5 sessions). Once lever pressing
was extinguished, there was a break period of 21 days following which
spontaneous recovery of lever pressing behavior was tested in a single session
where lever presses were recorded across the 30-minute session and resulted in
cue presentation alone.

N-acetylcysteine (NAC) Preparation
For animals in the NAC treatment group across both experiments, NAC was
delivered at a dose of 100 mg/kg intraperitonially (IP) and was prepared on the day
of injection following previously published methods (Garcia-Keller et al. 2019). To
achieve this concentration, 5 grams of NAC (Millipore Sigma) was added to 5 mL
of 27 mg/mL NaOH in 0.9% saline. Since this solution is acidic, 200 mg/mL NaOH
in saline was added in 50 uL increments until the solution reached a pH of ~7.5.
On the day of injection, animals were weighed and dosed accordingly.
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Statistical Analyses
These behavioral data were analyzed using SPSS version 23.0 software
(SPSS Inc., Chicago, IL) and Prism version 8 (GraphPad software, La Jolla, CA).
All experiments used an n of 8 animals/treatment group, and a p value of less than
0.05 was considered statistically significant. The primary dependent variable
measured for Experiment 1 was either infusions received, well entries completed,
or average lever pressing for each of the training and test phases. Behavioral data
from Phase1A-1C, Side Preference, and Phase Cue trials were analyzed using a
2-way ANOVA with Holm-Sidak multiple comparisons as the post-hoc test used to
determine differences between each treatment group. Trials completed in the setshifting test were analyzed using an ordinary one-way ANOVA with Holm-Sidak
multiple comparisons test used to compare all five treatment groups while errors
made during this test were analyzed through a 2-way ANOVA with a Holm-Sidak
multiple comparisons test. For Experiment 2, lever pressing behavior throughout
self-administration, extinction, and spontaneous recovery were analyzed using a
2-way ANOVA with a Holm-Sidak multiple comparisons test to compare across
treatment groups. Animals in Experiment 1 were eliminated from the experiment if
they did not meet criteria of 10 correct lever presses within these two set-shifting
testing sessions. Additionally, animals were eliminated from Experiment 2 if they
did not meet self-administration criteria during the second phase of acquisition
where ethanol concentration was at 10%.
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Results
Two main experiments were completed to determine the effects of
adolescent exposure to THC and ethanol on prefrontal cortex reliant behaviors
including cognitive flexibility and drug seeking. Generally, animals across all
experiments were exposed to THC vapor during mid-adolescence prior to
behavioral testing across these two behavioral paradigms to widely assess
behavioral responses to prefrontal cortex reliant tasks.

Effects of adolescent THC and ethanol exposure on cognitive flexibility
Experiment 1 was comprised of 40 male animals across the following
treatment groups: Air exposed controls, THC exposed, CIE exposed, both THC +
CIE exposed, and THC + CIE exposed animals that also received NAC (n =
8/group). Following the design outlined in Figure 5-1, animals were first exposed
to THC vapor for a total of five days in which animals in the NAC treatment groups
received injections directly after each exposure session. THC concentrations in the
blood using this method of vapor administration has previously been established
(Spencer et al. 2019) and, thus, was not obtained for these experiments.
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CIE exposure commenced following the completion of THC exposure and
behavioral intoxication ratings were taken following each night of exposure to
confirm that animals were maintaining a moderate level of intoxication throughout
the procedure (Figure 5-2). Animals were exposed to a total of eight nights of CIE
vapor exposure with a goal of a behavioral intoxication rating of ~2-3 which
corresponds to a blood ethanol concentration of ~250 mg% (Gass et al. 2016,
Smiley et al. 2020).
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THC and CIE treated animals sought increased amounts of sucrose during setshifting training
Set-shifting training commenced two days following the completion of CIE,
and lever pressing for sucrose was monitored throughout all five training phases.
During Phase1A animals were required to press either the right or left lever to
receive a sucrose reward and trials continued daily until all animals met a criteria
of ~50 lever presses within the 30-minute session. There was a significant effect
of treatment on the number of infusions received and the number of well entries
performed throughout Phase1A, with THC+CIE animals as well as animals
exposed only to CIE exhibiting increases in sucrose seeking (Figure 5-3A) [F (4,
70) = 15.0, p < 0.0001]. Following Phase1A, animals were trained on retractable
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levers in Phase1B where both levers were retracted following each lever press.
Increases in sucrose seeking were observed in drug treated animals in this phase
as well [F (4, 70) = 3.795, p = 0.0075], where THC+CIE and CIE treated animals
performed more well entries than control groups while the number of infusions that
were received remained similar between the groups (Figure 5-3B). This trend
continued throughout Phase1C, where animals were trained to ten-second
presentations of the levers. A similar effect was observed, where CIE exposed
animals maintained an increased numbers of infusions as well as well entries
compared to other treatment groups [F (4, 70) = 20.89, p < 0.0001] (Figure 5-3C).
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These first three phases trained animals to lever press to receive sucrose
in a manner that was specific to a ten-second availability followed by lever
retraction. Next, animals were tested in a side-preference test to determine if they
preferred either lever location. This test found that all animals exhibited a right lever
preference (Figure 5-4A) and, thus, all subsequent testing used a left lever active
program for the results not to be skewed by any innate lever preference. The final
training phase of the set-shifting task was PhaseCue in which animals were trained
to press either the right or left lever in response to an illuminated stimulus light that
appeared above the lever. All animals had to press the indicated lever 8 times in
sequence in a maximum of 30 trials to move on from this phase, and, while this
criteria was the same between the groups and all animals received the same
amount of reinforcers, those previously exposed to both THC+CIE performed more
well entries for sucrose during this session [F (4, 70) = 4.786 p = 0.0018] (Figure
5-4B).

128

Animals exposed to THC and CIE during adolescence display impairments in
cognitive flexibility
Once these five training phases were completed, animals were tested on a
between session set-shift to measure cognitive flexibility. During this test, animals
were required to only press the left lever regardless of where the stimulus light was
illuminated. The number of trials required for animals to learn this new rule and the
number of perseverative and regressive errors that were performed when animals
made an incorrect lever choice were recorded during this test. These studies found
that THC+CIE exposed animals took an increased number of trials to meet criteria
during the set-shifting test [F (4, 29) = 3.615, p = 0.0165], and that the increase
was due to these animals performing more perseverative errors, or errors that
occurred prior to successfully completing five correct lever presses (p = 0.0135),
both of which indicate that THC+CIE exposed animals exhibit impairments in
cognitive flexibility (Figure 5-5B). Additionally, this increase in both trials to criteria
as well as perseverative errors was prevented by NAC treatment in THC+CIE
exposed animals.
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Effects of adolescent THC exposure on ethanol seeking in adulthood
Experiment 2 was completed using 48 male animals within the following
treatment groups: Adolescents: THC, Air, THC+NAC, Adults: THC, Air, THC+NAC
(n = 8/group). This experiment utilized the design outlined in Figure 5-6 where
animals were exposed to THC vapor for a total of five days and those in the NAC
treatment groups received injections directly following each exposure session.
Ethanol self-administration began following THC exposure and consisted of a total
of 30 sessions, the first fifteen in which animals received 20% ethanol followed by
fifteen subsequent sessions at 10% ethanol. Following successful acquisition of
self-administration behavior, all animals were put through a week of extinction and

130

then a three-week break occurred before animals were tested for spontaneous
recovery of ethanol seeking behavior.

Animals exhibit escalations in ethanol seeking during acquisition and extinction
when exposed to THC during adolescence, but not adulthood
Following exposure to THC during either adolescence or adulthood,
animals began training in self-administration paradigms. There was a significant
effect of treatment [F (5, 19.67) = 2.909, p = 0.0398] on lever pressing behavior
across all of self-administration, with animals exposed to THC during adolescence
performing a significantly increased number of lever presses when compared to
air exposed controls (Figure 5-7A). Notably, this effect was not present when THC
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exposure occurred during adulthood. Similarly, this increase in ethanol seeking
was also observed with regards to the number of reinforcers received throughout
self-administration [F (5, 22.58) = 3.027, p = 0.0309], and was observed for
adolescents but not adults (Figure 5-7B).

but
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A similar effect was observed during extinction training, where adolescent
animals exposed to THC performed an increased number of lever presses during
extinction when compared to air exposed animals [F (2, 102) = 4.943, p = 0.0089]
(Figure 5-8A), and this was not observed in animals exposed to THC during
adulthood [F (2, 96) = 2.121, p = 0.1255] (Figure 5-8B).

This trend was carried over into spontaneous recovery testing where, while
there were no effects of THC exposure on lever pressing during spontaneous
recovery when compared to air exposed animals [F (5, 14.98) = 1.432, p = 0.2692],
THC exposed adolescents performed more lever presses during this test when
compared to THC exposed adults (p = 0.0364) (Figure 5-9A).
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Discussion
In summary, these experiments determined that exposure to THC and CIE
during adolescence leads to impairments in cognitive flexibly shown by increases
in trials to criteria as well as perseverative errors in a set-shifting test. Additionally,
in Experiment 2, we observed that animals exposed to THC during adolescence
increase ethanol seeking during self-administration, shown by increased lever
pressing behavior, and that, in general, adolescent animals seek ethanol at an
increased rate compared to adults. These experiment provide evidence that THC
exposure during adolescence can have deleterious effects on prefrontal cortex
134

reliant cognitive tasks such as set-shifting and drug-seeking, and NAC is able to
reverse these cognitive deficits.
While the data presented support the literature with regards to the effects
of THC on cognition and drug-seeking behaviors, there are a number of limitations
that need to be addressed. First, while adult groups were included for the analysis
of ethanol seeking, no adults were tested in the experiments that involved cognitive
flexibility testing. Although this is an important group that needs to be included to
make conclusions regarding the specificity of this effect to the adolescent
population, the specificity of these effects to the adolescent population is supported
by previously published literature (Szkudlarek et al. 2019). Additionally, during CIE
exposure, blood was not taken to test for blood ethanol concentration (BEC) to
make sure that animals were appropriately intoxicated. From data collected across
a variety of previous studies (Smiley et al. 2020; Trantham-Davidson et al. 2014;
Gass et al. 2014a, Gass et al. 2017, Uys et al. 2016), we have determined that a
behavioral rating of 2-3 will consistently be associated with a BEC of ~200-300
mg/dl and, thus, did not take samples from these animals. Further, these studies
did not include a treatment group that received NAC in the absence of any other
drug treatment. Preclinical studies completed using NAC to reduce neurotoxicity
have found that NAC treated animals did not differ from controls, and an insult had
to be present for NAC to impact oxidative injury and inflammation (Abdel-Wahab
and Moussa 2019). This data is supported by our previous studies using NAC to
prevent stress induced increases in drug relapse that found control animals treated
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with NAC did not exhibit any behavioral differences (Garcia-Keller et al. 2020).
Therefore, for these studies, we expect a NAC treated group to exhibit no
differences in behavioral outcomes when compared to controls.
In conclusion, these studies found that adolescent exposure to THC and
ethanol leads to deficits in prefrontal cortex reliant cognition, including set-shifting
and drug seeking behaviors. These deficits could potentially be a result of
impairments in glutamate functioning since NAC treatment led to reductions in
ethanol seeking and increased cognitive flexibility in THC and CIE exposed
animals. Further studies are needed to determine the exact mechanism of action
that these drugs are following to exert these effects, but these studies supply
valuable information regarding the behavioral effects of adolescent exposure to
these drugs and a possible preventative treatment with NAC.
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CHAPTER 6

EXPOSURE TO THC AND ETHANOL DURING
ADOLESCENCE HEIGHTENS RESPONSES TO FEAR
STIMULI DUE TO SIGNALING CHANGES IN THE
PRELIMIBIC CORTEX

Background and Significance
Cannabis has become the most commonly used illicit drug that is
increasingly being used for recreational purposes, with only ~10% of users citing
use for exclusively medicinal reasons (National Academies of Sciences, 2017). As
the rate of cannabis use has increased from 4.1% in 2002 to 9.5% in 2013 (Hasin
et al. 2015) and almost all age groups have shown increases in past-month use
within this time period (National Academies of Sciences, 2017). The population in
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which heavy use and high intensity use is most prevalent is late adolescence,
which is also the average age at which CUD is shown to develop (Hasin et al.
2016). Surveys of high school students reveal that ~50% of seniors have tried
marijuana while 5% of them participate in daily use (Schweinsburg et al. 2008).
While CUD itself is associated with adverse consequences, such as deficits in
cognition and attention, this disorder is also highly comorbid with other substance
use and psychiatric disorders that further add to these cognitive impairments.
Clinically, CUD patients are observed to have up to a 10 times greater chance of
developing alcohol use disorder (Hasin et al. 2015) and that ~80% of those with
CUD also have AUD (Hasin et al. 2016). This comorbidity is also present for CUD
and post-traumatic stress disorder, where CUD leads to a greater chance of
developing PTSD and, conversely, PTSD leads to higher rates of cannabis abuse
as well (Yarnell et al. 2015). This is especially true for the adolescent population,
in which marijuana is the most commonly used illicit substance by adolescents with
PTSD, and an adolescent with PTSD also has a two-fold increase in the likelihood
of developing CUD (Bujarski et al. 2012). Exposure to trauma also increases
alcohol use, especially when it occurs during adolescence, a period in which there
are already high rates of binge drinking (Khoury et al. 2010). While the comorbidity
between CUD with AUD and PTSD is extremely clinically relevant, there has been
a lack of pre-clinical research into the underlying brain mechanisms that contribute
to the maintenance and treatment of these co-morbid disorders. Therefore, in
these experiments, we examined the impact of adolescent exposure to cannabis
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and alcohol on responses to fear stimuli and sought to determine the underlying
signaling changes responsible for these alterations.

Materials and Methods

Animals
Male Wistar rats were Postnatal Day 28 and ~100 grams on arrival and
were individually house in standard polycarbonate cages. Animals were permitted
one week to habituate to a 12/12 reverse light-dark cycle with lights off at 0900,
allowing for behavioral testing to occur during the dark phase of the cycle. All
experiments had prior approval by the Institutional Animal Care and Use
Committee at the Medical University of South Carolina and were completed within
guidelines set forth by the National Research Council’s Guideline for the Care and
Use of Mammals in Neuroscience and Behavioral Research (2003). A total of 88
animals were used for this experiment and were broken up into the following
treatment groups: Air, THC, CIE, THC+CIE, THC+CIE+NAC (n = 16/group). A
subset of animals from each group (n = 8/group) received surgical implants to
monitor brain activity during these behavioral paradigms (n = 8/group). A
supplemental group was added that only received NAC treatment in the absence
of all other drug manipulations and was only tested on the behavioral aspects of
this experiment (n = 8). The general outline of the experimental design for these
studies is outlined in Figure 6-1.
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Surgical Procedures
For the subset of animals used to analyze brain signaling in response to
fear conditioning, fiber photometry was used to measure calcium transients
induced by neuronal signaling in real time during behavioral testing. Animals were
injected with a virus containing genetically encoded calcium indicators to be used
as a correlative measure of neural activity. Surgeries occurred between PD 35-36
and were followed by a one-week recovery period. Rats were anesthetized using
vaporized isoflurane and oxygen (flow rate of 0.4 L/min, 5% for induction and 2.53.5% for maintenance) and were mounted in a stereotaxic apparatus once fully
under (Kopf Instruments, Tujunga, CA). An adeno-associated virus encoding
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GCaMP6f with a promoter for CaMKII (AAV1-CaMKII-GCaMP6f, AddGene,
Watertown, MA) was injected into the prelimbic cortex (PrL) using a microsyringe
(Hamilton Company, Reno, NV) at a volume of 300 nL and a rate of 1 nL/s. The
PrL coordinates used in these surgeries were based on pilot experiments that used
dye injections to optimize the PrL location in PD 35 animals (in mm from bregma
and the skull surface, anterior/posterior +3.2, medial/lateral ± 0.6, and
dorsal/ventral −2.8). There was a ten-minute period allowed for virus infusion
following injection,. A handmade optical fiber probe (400 μm diameter patch cord
in a 2. 5 mm ferrule, Thorlabs) was then implanted at the same coordinates. Two
stainless steel screws were mounted in the skull and were covered in dental
cement to keep the probe in place. The surgical incision was treated with 2% triple
antibiotic ointment and 2% xylocaine directly after surgery and antibiotic ointment
was applied as needed in the following days. Additionally, the following drugs at
the listed doses were administered to each animal directly following surgery:
ketorolac (body weight/1000), dexamethasone (body weight/1000), and saline
(body weight/100) cefazolin (1/2 body weight/100). For post-operative care,
ketorolac was used for pain management and delivered the day following surgery
with cefazolin antibiotic administered for two days following surgery.

Adolescent THC Vapor Exposure
Once animals were allowed one week for surgical recovery, exposure to
THC vapor occurred following the method established by Spencer et. al. (2018).
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Starting at PD 40, each animal received a total of 20 minutes of vapor exposure
per day for 5 days. Each THC exposure session was broken up into 5-minute
administrations, with two in the morning and two in the afternoon following a threehour break, to keep THC concentrations steady. Each exposure session used a
vaporized solution consisting of THC at a concentration of 200 mg per mL of
ethanol and CBD at 20 mg per mL of ethanol. These solutions were mixed at a
1:1:1 ratio with glycerol to obtain a final solution containing THC and CBD at a ratio
of 10:1. Aliquots of 150 uL of this solution were vaporized using a Volcano (Storz
and Bickel, Oakland, CA) and the resulting vapor was administered equally among
the animals. If animals were assigned to the NAC treatment group, they received
intraperitoneal (IP) injections of the drug immediately following both the morning
as well as the afternoon session. Following the five total days of THC exposure,
animals were permitted a two-day break before entering chronic intermittent
ethanol exposure (CIE).

Chronic Intermittent Ethanol Exposure (CIE)
CIE commenced on PD 50 and was used to model binge-like alcohol
consumption using repeated cycles of ethanol vapor exposure and abstinence.
This paradigm consisted of four nights of vapor exposure from 1800-0800 (14
hours on/10 hours off) followed by a two-day break, and this cycle was completed
a total of two times. A five-point behavioral scale was used to grade intoxication
levels based on motor behavior. Rats were assigned the following scores based
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on behaviors exhibited when taken out of the chambers in the mornings: 1: no
signs of intoxication and no motor impairment, 2: slight intoxication and slight motor
impairment, 3: moderate intoxication with obvious motor impairment but retains the
ability to walk, 4: loss of righting reflex, highly intoxicated, 5: loss of righting reflex
and eye blink reflex, extremely intoxicated (Nixon and Crews, 2002). An
intoxication rating of 2-3 was the goal of each CIE session which corresponds to a
blood ethanol concentration (BEC) of ~250 mg/dl. Animals in the NAC treatment
group received injections two hours prior to CIE exposure and immediately after
they came out of the chambers in the morning.

N-acetylcysteine (NAC) Preparation
NAC was administered at a dose of 100 mg/kg and was prepared on the
day of injection. This dose was chosen to optimize the effects of NAC on the
glutamate system based on previous experiments (Garcia-Keller et al. 2019). To
achieve this concentration, 5 grams of NAC (Millipore Sigma) was added to 5 mL
of 27 mg/mL NaOH in 0.9% saline. Since NAC is acidic, 200 mg/mL NaOH in saline
was added in 50 uL increments until the solution reaches ~pH 7.5. On the day of
injection animals were weighed and dosed accordingly and injections were
delivered intraperitonially (IP).
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Fear Conditioning Procedure
Two days following the end of CIE exposure, fear conditioning was used to
determine differences in behavioral responses to fear stimuli and followed
previously published methods (Cain et al. 2002, Holmes et al. 2012, Izquierdo et
al. 2006, Sinclair et al. 2012, Wellman et al. 2007). This paradigm consisted of
exposure to multiple tone/shock pairings to measure behavioral responses to the
tone over time and between treatment groups. Each trial lasted approximately five
minutes each and occurred once a day for three days total. Conditioning sessions
consisted of an initial 120 second acclimation period followed by the presentation
of four tones (80 dB, 3 kHz) separated by a 10 second inter-stimulus interval. Each
tone was paired with a 0.75 mA shock that occurred during the final two seconds
of the tone. Animals were presented with a total of 12 tone/shock pairings across
three separate days. Trials were recorded and analyzed using AnyMaze software
to determine freezing behavior (Stoelting Co. Wood Dale, IL).

Calcium Imaging
In the subset of animals previously implanted with fiber optic probes,
calcium imaging was performed using a custom-built fiber photometry rig based
on the design of the Deisseroth (Lerner et al. 2015) and Woodward labs
(Braunscheidel et al. 2019). A LED driver (Thorlabs) provided both 405 nm and
490 nm illumination which were combined in a fluorescence mini-cube (Doric
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Lenses). A custom made 400 μm diameter patch cord terminating in a ceramic
sleeve was used to connect the mini-cube to the animal’s fiber optic implant.
Synapse software (TDT) was used to control a digital processor (TDT) that
received input from a photodetector (Newport) that collected emission signals at
both 405 nm and 490 nm. Integrated TTL signals were used to time-lock signals
with the start of each fear conditioning session as well as the presentation of each
tone throughout the session. Custom-written MatLab codes (MathWorks) were
used to analyze these data. Signals from the 405 and 490 nm channels were
subtracted from each other to calculate data as ΔF/F. Data for each testing day
was then z-normalized to a combined baseline of all signaling across the whole
session for that day.

Tail Immersion Test
Following the completion of all behavioral testing, animals in the surgical
subset groups were exposed to a tail immersion test to test for differences in pain
sensitivity between the groups. Prior to the test day, all animals were habituated
to handling and immersion using room temperature water. Additionally, each
animals’ tail was marked 3 cm above the tip to standardize immersion length. On
the day of the test, water was heated to 52°C and kept constant for each animal.
The tail was dipped into the water to the 3 cm mark and animals were held into the
water until their tail broke the surface. This was repeated for a total of three times
per animal in succession and immersion time was averaged across the three tests
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for each animal. This test was recorded and manually scored to determine average
immersion time for each animal and averaged across treatment group.

Statistical Analysis
Behavioral experiments included 12-16 animals per treatment group while
signaling data comprised 6-8 animals per group. The variation in sample size was
a result of the following exclusion criteria. Animals were eliminated from behavioral
experiments if they were not freezing over 50% of the time in response to the tone
on Conditioning Day #3 and from signaling experiments if the fiber optic probe did
not terminate above the virus in the prelimbic cortex. Data were analyzed using
Prism version 8 (GraphPad software, La Jolla, CA) and a p value of less than 0.05
was considered statistically significant. Fear conditioning data were analyzed
using a 2-way ANOVA with Holm-Sidak multiple comparisons as the post-hoc test
used to determine differences between each treatment group. Signaling data was
analyzed using a 1-way ANOVA with post-hoc testing completed using a HolmSidak multiple comparisons test.

Results

CIE exposure resulted in moderate levels of intoxication that were comparable
between the groups
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Behavioral intoxication ratings were complimented with blood ethanol values
to assess the level of intoxication for all CIE exposed animals across the three
ethanol exposed treatment groups. All animals achieved a moderate level of
intoxication with behavioral ratings of between 2-3 (Figure 6-2A) and BEC levels
of between 300-400 mg/dL (Figure 6-2B). Additionally, animals’ weights were
taken during each phase of the experiment to maintain health between the
groups, and there were no differences in weight between treatment groups
throughout the experiment (Figure 6-2C).
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Adolescent exposure to THC and CIE increases behavioral responding to fear
stimuli during conditioning

When conditioning behavior is examined as an average of percent freezing
during the tones per each conditioning day, there was a significant effect of
treatment [F (5, 215) = 12.81, p < 0.0001] such that THC+CIE and THC exposed
animals exhibited an increased freezing response to the tones on Conditioning
Day #2 when compared to all other treatment groups (Figure 6-3A). Additionally,
this effect carried over to Conditioning Day #3, where drug treated groups exhibited
heightened levels of freezing when compared to air treated controls as well as
THC+CIE exposed animals that also received NAC treatment concurrent with each
drug exposure (Figure 6-3A). During each conditioning day, animals received a
total of four tone/shock pairings and, thus, freezing to each individual tone
presentation were examined to determine when responses began to differentiate
between the groups. There was a significant effect of treatment in individual tone
responses [F (5, 860) = 27.66, p < 0.0001], with drug treated animals exhibiting a
consistent increase in freezing when compared to control and NAC treated animals
(Figure 6-3B). When comparing THC+CIE exposed animals vs. controls and NAC
treated animals, the initiation of this effect was in response to tone presentation #6
on Conditioning Day #2 where these animals began exhibiting a significant
increase in freezing to the tone (Figure 6-3B, p = 0.0274 vs. Air, p = 0.0059 vs.
THC+CIE+NAC).
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Increased freezing during conditioning is not associated with alterations in pain
tolerance

Following the completion of behavioral testing, all animals were exposed to a
tail immersion test to ensure that behavioral responding during conditioning was
not due to drug-related changes in pain sensitivity. There were no differences
observed between any of the treatment groups in average immersion time during
the tail immersion test designed to determine pain sensitivity (Figure 6-4) [F (4,
25) = 0.03744, p = 0.9971].
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THC and CIE exposure results in a freezing associated increase in prelimbic
signaling in response to the shock during conditioning

In addition to the behavioral measures taken during fear conditioning, a subset
of animals in each treatment group received fiber optic implants to measure
signaling from the prelimbic cortex during each session. While signaling data was
recorded throughout the session, the most variation in signaling was observed in
response to each shock presentation and, therefore, this is the data focused on in
this section. Each figure displays averaged signal from the prelimbic cortex across
animals between each treatment group from the five seconds prior to each shock
and five seconds following each shock, with the red mid-lines reflecting shock
onset. On Conditioning Day #1, while most groups exhibit an increase in PrL
activity following the shock, the magnitude of this difference differs between the
groups (Figure 6-5).

151

152

The magnitude of the PrL response to the shock is shown to differ between the
groups when the difference in signal prior to vs. following the shock is quantified
per each treatment group (Figure 6-6). In response to all four shock presentations
on Conditioning Day #1, THC+CIE treated animals exhibit a heightened PrL
response to the shock when compared to air exposed controls.

Further, signaling from Conditioning Day #3 reflects conditioned responding
while shock responses on Conditioning Day #1 reflect responses during early
phases of conditioning when animals have not yet formed a conditioned response.
On Conditioning Day #3, THC+CIE exposed animals exhibit an increase in signal
directly following each shock presentation (Figure 6-7).
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When quantifying signaling change in response to the shock on Conditioning
Day #3, THC+CIE exposed animals exhibit a heightened response to each of the
shocks when compared to air exposed animals as well as those exposed to
THC+CIE treated with NAC. Additionally, the magnitude of response observed in
the THC or CIE exposed animals is lower than when animals are exposed to both
drugs (Figure 6-8).

This difference between treatment groups as well as the difference between
responses on Conditioning Day #1 versus Day #3 are revealed when comparing
the average response to all shocks across each day (Figure 6-9). While the pattern
in shock responses on Conditioning Day #1 is not clear, by Conditioning Day #3,
group differences in signaling reflect the differences in freezing behavior shown in
Figure 6-3. There is a significant effect of treatment observed [F (4, 70) = 15.02,
p < 0.0001], where THC+CIE exposed animals exhibit a heightened PrL response
to the shocks on Conditioning Day #3 when compared to all other treatment groups
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(Figure 6-9). Virus and probe location in the PrL are depicted in Figure 6-10 to
ensure that all recordings were from within the boundaries of the PrL.
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Discussion

The results from these experiments indicate that THC and ethanol exposure
during adolescence leads to increases in fear responses that are associated with
a higher level of prelimbic signal in response to fearful stimuli. This effect was
greater with combined drug exposure than either drug alone, and, when these
animals were treated with NAC after each drug exposure, the behavioral and
signaling alterations observed following adolescent THC and ethanol exposure
were reversed. As such, these experiments identify the determinantal effects of
adolescent THC and ethanol exposure on future behavioral and neuronal
responses to fear stimuli. Further, these results support the hypothesis that
alterations in prelimbic signaling may underlie the clinical relationship between
adolescent drug exposure and development of PTSD.
These experiments examined pain sensitivity as an alternative explanation for
the group differences observed with regards to freezing behavior, but there are a
number of additional explanations that should be explored. First, exposure to these
drugs could be causing a reduction in motor activity during fear conditioning
paradigms that is recorded as increased freezing. While exposure to THC has
been shown to cause short term decreases in motor activity observed in open field
tests immediately following drug exposure, these are transient effects that are
dependent on the drug being onboard and were not present 48 hours later
(Bruijnzeel et al. 2016). Similarly, ethanol exposure has been shown to cause
alterations in motor behavior, but these effects have been shown to dissipate
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following the cessation of ethanol exposure (Ornelas et al. 2015). These motor
effects that occur as a consequence of ethanol exposure on motor sedation are
also less severe in adolescent animals when compared to adults (Acevedo et al.
2013, Little et al. 1996). As these experiments tested fear conditioning 18 days
following the last THC exposure and four days after the last CIE session, we do
not expect motor alterations as a result of these drugs to have impacted behavior
during fear conditioning. While these experiments focused on alterations in
prelimbic signaling, there are a number of fear related areas that could also be
affected as a result of THC and ethanol exposure during adolescence. There are
high levels of CB1 receptors in the amygdala, and cannabinoids are highly involved
in signaling in this region especially in the basolateral amygdala (BLA) (Katona et
al. 2001, Pistis et al. 2004, Phan et al. 2008). In general, adolescents exhibit
stronger amygdala reactivity in response to fearful stimuli when compared to adults
(Guyer et al. 2008). Additionally, it has been shown that adolescent cannabis users
exhibit increased amygdala reactivity in response to fearful stimuli along with
impaired discrimination between threat and neutral stimuli due to increases in
prefrontal cortex activity (Spechler et al. 2015). Preclinical studies also support this
effect, with animal models reporting inhibition of GABA transmission in the
amygdala following exposure to CB1 agonists (Katona et al. 2001). Further, when
animals were treated with THC and exposed to restraint stress, the effects on
inhibitory transmission in the amygdala were enhanced (Patel et al. 2004).
Therefore, while these experiments determined the effect of adolescent exposure
to THC and ethanol on prelimbic cortex signaling during fear stimuli presentation,
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future examinations of neuronal alterations following adolescent THC exposure
should include analysis of downstream amygdala activity.
These experiments determined that adolescent exposure to THC and ethanol
leads to increased behavioral and neuronal responding to fear stimuli during fear
conditioning. Additionally, NAC treatment administered directly after each drug
exposure session was able to prevent both the increased freezing exhibited during
conditioning as well as the heightened prelimbic signaling recorded following the
presentation of fear stimuli. These results are in accordance with the hypothesis
that adolescent drug exposure can induce neuronal alterations that may cause an
increased predisposition for developing disordered responses to fear stimuli that
underlie PTSD. Furthermore, the use of glutamatergic modulators to normalize
glutamate homeostasis in the prefrontal cortex could serve as a potential treatment
to reverse the deleterious effects of adolescent drug exposure.

159

CHAPTER 7

DISCUSSION

The studies presented in this dissertation establish the detrimental effects of
stress and drug exposure on multiple PFC-reliant behavioral tasks including drug
seeking, cognitive flexibly, and fear-cue reactivity. Further, these experiments
demonstrate that alterations in glutamatergic regulation in the prefrontal cortex are
responsible for the drug and stress induced changes in responses to fear and drug
cues. Finally, pharmacological modulators of glutamatergic function were used to
reverse these stress and drug induced deficits.
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N-acetylcysteine prevents stress induced alterations in alcohol seeking and
cognitive flexibly
Restraint stress exposure followed by testing in self-administration paradigms
revealed a stress induced increase in ethanol seeking during acquisition,
extinction, and stress cue induced reinstatement testing. Additionally, treatment
with N-acetylcysteine (NAC) delivered either prior to, following, or surrounding
restraint prevented the stress induced increases in ethanol seeking observed
throughout self-administration. Stress exposure was also found to cause
impairments in cognitive flexibility that were prevented with NAC treatment as well.
Previous studies have examined the relationship between stress exposure and
drug seeking across a wide variety of clinical studies as well as in preclinical
models. For these experiments, restraint stress was used as our stress model and
self-administration modeled ethanol seeking, but a variety of different techniques
for stress and drug administration have been tested. Alternate models have shown
increased drug seeking following stress exposure for drugs such as
methamphetamine, heroin, cocaine, and ethanol (Goeders and Geurin 1994, Liu
and Weiss 2002, Lewis et al. 2013, Pizzimenti et al. 2017, Shaham and Stewart
1994). In clinical studies, it has been shown that PTSD patients have an increased
rate of substance use disorders when compared to the general population and are
more likely to exhibit relapse events in response to stress associated cues
(Roberts et al. 2015, Tipps et al. 2014, Shaham and Stewart 2000). Additionally,
while those with PTSD and a co-morbid substance use disorder do not have
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increased severity of substance use, they do exhibit a higher incidence of relapse
compared to those with a substance use disorder alone (Tate et al. 2004, Najt et
al. 2011, Burns et al. 2010). These clinical and preclinical studies support the
results presented here, in which exposure to a stressor leads to increased ethanol
seeking throughout self-administration paradigms as well as increases in ethanol
seeking during fear cue-induced relapse testing. Additional results presented from
these experiments include examinations of stress effects on cognitive flexibly.
While these experiments determined that restraint stress exposure resulted in
deficits in cognitive flexibility, further reports in the literature have achieved mixed
results depending on the time scale of testing. In clinical studies, those exposed to
an acute stressor exhibited impairments in cognitive flexibility (Shields et al. 2016),
but this relationship has been shown to be more complicated in animal models with
impairments, enhancements, and no effects on cognitive flexibility reported in
rodent studies (Butts et al. 2013, Thai et al. 2013, George et al. 2015). Therefore,
due to the previous reporting of both stress induced increases in relapse-like
behavior and impairments in cognitive flexibility, the novelty of these experiments
comes from the use of N-acetylcysteine (NAC) to prevent these effects.
The overlap in cognitive control of ethanol seeking and deficits in set-shifting
is in the prefrontal cortex (PFC) and, thus, stress induced changes in PFC function
need to be examined to determine the possible mechanism of action NAC is
working through. The promotion of drug seeking behavior and strategy set-shifting
have been shown to be reliant on the medial prefrontal cortex (mPFC) with
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inactivation of the mPFC leading to increases in perseveration, similar to the
results observed in these experiments (Birrell and Brown 2000, Floresco et al.
2008). Additionally, stress exposure has a variety of deleterious consequences on
the structure and function of the mPFC (Arnsten 2009, Holmes and Wellman
2009). This region has been shown to be highly activated across a wide variety of
stressors, leading to downstream increases glucocorticoid (GC) responses to
stress (Ostrander et al. 2003, Herman et al. 2005, Singewald et al. 2003, Diorio et
al. 1993). Further, exposure to stress and increases in GC activation are
associated with morphological changes in these regions including dendritic
remodeling (Liston et al. 2006, Sapolsky 2003, Cerqueira et al. 2005). These stress
induced alterations in PFC structure have also been shown to be associated with
modifications in glutamatergic functioning in this region (Popoli et al. 2011). The
increase in GCs following exposure to physiological and environmental stressors
is associated with increases in glutamate release in the PFC, and has been
measured across multiple animal models including restraint stress, forced swim,
foot-shock, and direct GC administration (Lowy et al. 1993, Moghaddam 1993,
Musazzi et al. 2010). This increase in glutamate following stress is not only
transient, since there are delayed and long-term effects on PFC glutamate function
(Yuen et al. 2009, Yuen et al. 2011). Stress induced alterations in PFC glutamate
are also associated with alterations in synaptic plasticity, including impairments in
LTP in PFC to hippocampus signaling (Rocher et al. 2004, Mailliet et al. 2008).
This is especially important for these experiments, as these signaling impairments
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are associated with deficits in PFC-reliant behaviors including cognitive flexibly
(Cerqueira et al. 2007).
The results from these experiments determined that N-acetylcysteine (NAC)
had the ability to prevent fear-cue induced relapse and impairments in cognitive
flexibility that occur following exposure to an acute stressor. These results are
supported by clinical studies that used NAC in veterans with co-morbid PTSD and
SUD and recorded reductions in both drug use and PTSD symptoms following this
treatment (Back et al. 2016). Additionally, NAC may be affecting stress induced
impairments in prefrontal glutamatergic functioning to impart these effects (Dean
et al. 2011). NAC has been shown to have a restorative effect on deficient
glutamatergic systems as a result of drug exposure across multiple addiction
models (Knackstedt et al. 2009, Madayag et al. 2007). Further, NAC has been
shown to have effects on oxidative stress and inflammation in the brain which could
serve as additional candidates for the mechanism of action at work in these
experiments (Dean et al. 2011). While NAC has widespread effects on brain
function, the glutamatergic or inflammatory systems in the brain could be a
potential mechanism of action for these experiments due to the overlapping effects
of stress on these processes.
In summary, these experiments determined that acute stress exposure leads
to increases in ethanol seeking during self-administration and stress-cue induced
reinstatement and leads to impairments in cognitive flexibility, both of which are
prevented with N-acetylcysteine treatment surrounding the stressor. NAC may
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potentially be regulating glutamate homeostasis in the prefrontal cortex to impart
these effects, but further studies are required to determine the exact mechanism
of action. These results add to the established body of literature examining the
detrimental effects of stress exposure on prefrontal cortex reliant cognition and
provide further evidence to support the use of NAC in comorbid PTSD/AUD.

Chronic ethanol exposure leads to deficits in fear extinction learning through
alterations in mGlu5 signaling in the infralimbic cortex
This set of studies modeled PTSD/AUD in rodents using fear conditioning
followed by CIE and found that ethanol exposure leads to impairments in fear
extinction learning in both sexes. Additionally, using CDPPB and microinjections,
these results determined that the effects of ethanol on fear learning are dependent
on mGlu5 signaling in the infralimbic subregion of the prefrontal cortex. Further,
these studies establish multiple sex differences with regards to responses to fear
stimuli during conditioning and recall.
Increasing evidence has implicated the PFC in the extinction of both fear and
drug-seeking behaviors. These converging lines of evidence from the fields of fear
and drug research suggest that the PrL cortex functions as an “on-switch” for fear
expression and drug-seeking, while the IfL cortex functions as an “off -switch” to
allow for the expression of extinction behavior (Quirk et al. 2010; LaLumiere and
Kalivas 2008; LaLumiere et al. 2010; Peters et al. 2009). While the majority of
studies investigating the role of the PrL and IfL subregions support our current
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findings, there are a small number of published manuscripts that suggest
alternative roles of these structures in extinction learning. For example, Marek and
colleagues (Marek et al. 2018) have highlighted the impact of PrL to IfL projections.
Specifically, the PrL has been shown to send excitatory afferents to neurons in the
IfL, some of which project to the amygdala. Using c-Fos expression as a measure
of neuronal activity, they found that PrL neurons that project to the IfL were active
during extinction learning and optogenetic stimulation of these PrL to IfL afferents
resulted in facilitated extinction learning (Marek et al. 2018). While these findings
provide a greater role for the PrL in extinction learning, they still highlight the
importance of these PFC subregions in extinction-related behaviors. Although not
directly examined in the current set of studies there has been a substantial amount
of research implicating areas of the amygdala in the extinction of fear conditioning
(Quirk et al. 2010; Sierra-Mercado et al. 2011; Meyers and Davis 2002; Meyers
and Davis 2007). In addition to extinction learning, a number of studies have also
shown that subregions of the amygdala are involved in fear memory
reconsolidation (Parsons and Gafford et al. 2006; Parsons, Gafford, and Baruch
et al. 2006; Nader et al. 2000; Debiec et al. 2006; Doyere et al. 2007). Given the
substantial impact that alcohol abuse has on both the PFC (Abernathy et al. 2010;
Tu et al. 2007) and the amygdala (Koob 2009; Silberman et al. 2009; McCool et
al. 2010), it is logical to assume that CIE alters the neurocircuitry between these
brain regions, potentially causing the changes in extinction learning and memory
recall that were observed in these studies.
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These studies also established the ability of CDPPB, an mGlu5 positive
allosteric modulator, to reverse CIE induced deficits in fear extinction learning.
From a translational perspective, the glutamatergic system is one of the most
investigated neurotransmitter systems involved in memory-based treatment
approaches. Manipulation of both ionotropic and metabotropic glutamate receptors
alters extinction learning of fear and drug-seeking behaviors as well as the
reconsolidation of these memories (Gass and Chandler 2013; Cleva et al. 2010;
Gass and Olive 2008; Meyers et al. 2011; Sorg 2012). However, given the negative
side effects associated with direct NMDA enhancement, a focus has been placed
on investigating the impact of mGluR manipulation on fear and drug memories.
Generally, enhancement of mGluR activity has been shown to facilitate extinction
learning for fear (Sethna and Wang 2014) and drug-seeking behaviors (Gass and
Chandler 2013; Cleva et al. 2010; Singewald et al. 2014). Additionally, our lab has
shown that positive allosteric modulation of mGlu5 facilitates the extinction of
cocaine- (Gass and Olive 2009a; Cleva et al. 2011) and alcohol-seeking (Gass et
al. 2014). Additional studies have focused on the role of mGlu5 in the prefrontal
cortex on fear extinction. It has been shown that the consolidation of fear extinction
memories is dependent on mGlu5 activity in the IfL and enhancement of this
activity can contribute to fear extinction (Fontanez-Nuein et al. 2011). Furthermore,
genetic deletion of mGlu5 leads to impairments in the acquisition and extinction of
fear behaviors (Xu et al. 2009). In total, these studies all highlight the necessity of
mGlu5 signaling in fear learning and extinction and utilize this function for the
treatment of comorbid PTSD/AUD.
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In support of the sex differences observed with regards to behavioral
responses during conditioning and recall, these fear-related learning and memory
processes have also been shown to differ between the sexes. Multiple lines of
inquiry have found sex differences in fear responses that involve the medial
prefrontal cortex. Further, these differences have been found in both behavioral
and molecular studies. Behaviorally, sex differences have been established during
fear conditioning (Fenton et al. 2016; Keiser et al. 2017), extinction (Voulo and
Parsons 2017; Velasco et al. 2019; Matsuda et al. 2015), and recall (Baran et al,
2009; Keiser et al. 2017, Shvil et al. 2014). Females have also been shown to
exhibit more active fear avoidance strategies, such as darting rather than freezing,
which could account for the behavioral differences observed in these studies
(Gruene et al. 2015). Furthermore, while females in different estrous phases have
been shown to extinguish fear behavior at the same rate, these same animals
exhibit lower levels of freezing in recall testing when in proestrus compared to
metestrus (Maeng et al. 2015). The determination of differential fear response
strategies between the sexes is an important factor when examining behavioral
data and would be a valuable analysis for further fear related studies. Additionally,
there are a number of differences between the sexes in the circuitry and biological
mechanisms responsible for fear learning (Ramikie and Ressler, 2017). When
examining auditory fear memories, it has been shown that females exhibit
enhanced learned fear expression that is associated with elevated gamma
oscillations in the medial prefrontal cortex (Fenton et al. 2016). Gamma oscillations
have been shown to play a role in memory processing in the prefrontal cortex and
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have been shown to be involved in fear learning in both preclinical (Fitzgerald et
al. 2014) and clinical populations (Mueller et al. 2014). Therefore, innate signaling
differences between males and females in the mPFC could be playing a role in the
sex differences we observed during fear conditioning. The PFC is a sexually
dimorphic brain area with females having large populations of estrogen receptors
in this region (Almey et al. 2014). Estrogen has been shown to affect long term
potentiation and synapses in the mPFC which could be involved in the underlying
cause of multiple sex differences exhibited during fear learning processes (Galvin
and Ninan 2014; Gupta et al. 2001; Shanmugan and Epperson 2014; Zeidan et al.
2011). Sex differences have also been established in glutamatergic systems where
females exhibit higher levels of glutamate when compared to males in a variety of
brain regions, and there is differential glutamate expression across the estrous
cycle (Wickens et al. 2018). Additionally, there are known interactions between
estrogen receptors and metabotropic glutamate receptors in females (Tonn
Eisinger et al. 2018; Kasten et al. 2019) that could affect the prefrontal cortex and
therefore affect responses to fear stimuli.
In conclusion, these studies demonstrate the deleterious effects of chronic
ethanol exposure on fear extinction learning and establish mGlu5 activity in the IfL
as a potential mechanism of action through which ethanol induces these effects.
CDPPB as a glutamatergic modulator was also shown to be effective at reducing
the harmful effects of ethanol, and supports the use of glutamatergic modulation
for the treatment of comorbid PTSD/AUD.
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Optogenetic inhibition of the prelimbic cortex during fear memory reconsolidation
facilitates extinction learning in ethanol exposed animals
These studies were completed to examine the effects of prefrontal cortex
manipulation following fear memory recall on future responses to fear stimuli. By
optogenetically inhibiting the PrL cortex during fear memory reconsolidation, we
were able to enhance extinction learning in a model of PTSD/AUD. These effects
were specific to the PrL cortex, as repetition of this experiment with inhibition of
the IfL cortex did cause any effects on fear extinction learning. Further, these
experiments confirmed these results in both sexes and also led to long term
changes in responses to fear stimuli during spontaneous recovery testing.
The acquisition and maintenance of psychiatric disorders such as PTSD and
AUD rely on the fundamental principles of learning and memory. Based on
classical theories of learning and memory, the environment in which the patient
experiences the traumatic event can become a conditioned stimulus (CS) and the
fear response that the person has to the trauma environment and cues will then
become a conditioned response (CR). Further experiencing of the environmental
cues can reinforce the association between the cues (CS) and the fear response
(CR) which leads to PTSD symptoms such as such as re-experiencing the trauma
through flashbacks and nightmares in response to trauma associated cues
(VanElazakker et al. 2013). These principles are often applied clinically for the
treatment of PTSD and AUD through techniques such as exposure therapy.
Repeated exposure to the trauma-associated environment (CS) in a safe location
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can help decrease the fear response (CR) to these cues in a process known as
extinction learning (Merlo et al. 2014). Subsequent cue presentation offers a
unique period of time where intervention can be made to disrupt the association
between the trauma associated cues and the fear response. However, when
alcohol is used to self-medicate in response to the PTSD symptoms, there are
deficits in extinction learning which render these therapies unsuccessful (Conklin
and Tiffany 2002; Back et al. 2014). These results are replicated preclinically in
studies that establish impairments in fear extinction learning following binge
ethanol exposure (Smiley et al. 2020). Therefore, in situations where chronic
alcohol exposure occurs following trauma exposure, supplemental therapeutics
are needed to treat PTSD symptoms. The two clinical mechanisms for enhancing
these processes include the enhancement of extinction learning and the blockade
of fear memory reconsolidation (Giustino et al. 2016). Our previous study was able
to treat the behavioral deficits that occur with co-morbid PTSD/AUD through the
first strategy by using a pharmacological modulator of mGlu5 to enhance extinction
(Smiley et al. 2020). The present study utilized the second mechanism by using
optogenetics to block fear memory reconsolidation. By blocking the activity of the
PrL during fear memory reconsolidation, we stopped the “fear promotion” input to
the memory engram (Kitamura et al. 2017; Tonegawa et al. 2015; 2018).
Therefore, when fear memory recall is induced through exposure to the fear
associated cues and environment, PrL activity is reduced and, behaviorally, we
record a reduced fear response. While invasive brain manipulation techniques are
not practical for human use, there has been recent research into therapeutic
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agents that result in the inhibition of fear memory reconsolidation. For example,
propranolol has become a popular pharmaceutical to use in conjunction with
behavioral therapies to affect more successful treatment outcomes for PTSD
patients by blocking fear memory reconsolidation (Giustino et al. 2016; Brunet et
al. 2014; Schwabe et al. 2012). The data presented here provide novel evidence
that the manipulation of fear memory reconsolidation is a viable treatment strategy
for extinction learning deficits that are introduced through exposure to chronic
alcohol following stress exposure in a model of comorbid PTSD/AUD.
Previous studies have found conflicting results regarding the effects of ethanol
exposure on fear learning, but it is important to examine each study separately
with regards to the specific model used for both fear conditioning as well as ethanol
exposure. When animals were conditioned using six tone/shock pairings followed
by injections of 30% ethanol for five days, ethanol exposure was found to cause a
strengthening of the fear memories that were established during conditioning
(Quiñones-Laracuente et al. 2015). These animals exhibited an increased freezing
response when compared to vehicle injected animals across extinction training and
in a single extinction recall test the following day. However, these effects were only
displayed when extinction training occurred directly following ethanol exposure,
since when extinction testing occurred 10 days following ethanol injections there
was no change in freezing during extinction (Quiñones-Laracuente et al. 2015).
The main differences between this previously published data and the results
presented here are in the fear conditioning (12 tone/shock pairings vs. 6) and
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ethanol exposure (14 days vapor exposure to 100% ethanol vs. 5 days of injections
of 30% ethanol). Supporting evidence comes from mouse studies that determined
the ability of ethanol to cause changes in fear learning and the glutamatergic
system. These experiments were completed using a similar CIE model that found
that ethanol exposure resulted in increased levels of freezing during extinction and
retrieval testing that was associated with increased dendritic arborization in the PrL
(Holmes et al. 2012). Additionally, these studies showed that a shorter CIE
paradigm was not able to induce these effects (Holmes et al. 2012). Thus, the
more intensive paradigm used for these studies could lead to longer lasting
changes in prefrontal glutamate signaling as well as behavioral responses to fear
cues.
Taken together, these studies suggest that inhibition of the PrL, but not the IfL,
during fear memory reconsolidation facilitates extinction learning and prevents
increased freezing during memory reconsolidation in both male and female
animals in a preclinical model of PTSD/AUD. These studies support the use of
modulation of memory reconsolidation for the treatment of learning and memory
deficits that occur as a result of exposure to stress and chronic alcohol and, further,
identify specific time-points and brain regions that are necessary for this treatment
effect.
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Adolescent exposure to THC results in impairments in cognitive flexibly and
increases in ethanol seeking in adulthood
Previous studies illustrate the long-term effects on cognition that occur as a
result of chronic cannabis use during adolescence (Jacobus and Tapert 2014).
Clinically, cannabis exposure during adolescence results in impairments in
memory performance (Silva de Melo et al. 2005) that persist even after prolonged
abstinence (Schwartz et al. 1989). Additionally, cognitive flexibility has been
examined in preclinical models where set-shifting was tested following exposure
to various models of prolonged cannabis exposure (Gomes et al. 2014, Szkudlarek
et al. 2019). These studies found that, while adolescent exposure to cannabinoid
agonists induces deficits in strategy set shifting (Gomes et al. 2014), adult
exposure to THC does not result in alterations in this behavioral task (Szkudlarek
et al. 2019). Further, clinical studies have determined the effects of alcohol,
cannabis, and use of both substances on cognition and have found that
concomitant use of alcohol and cannabis by adolescents leads to deficits in
cognitive flexibility (Winward et al. 2014). Thus, the results reported from the
present experiment are in accordance with the literature, and further these data by
using a mix of THC/CBD at a concentration that is clinically relevant.
Additionally, prior studies have shown that cannabis exposure can impact
drug use in the future (Chadwick et al. 2013). Longitudinal studies have shown that
adolescent cannabis use will positively predict levels of alcohol use for the
following year, and further studies determined that ~25% of illicit drug users have
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had previous cannabis exposure (Newcomb and Bentler 1986). This effect has
also been shown to be dependent on cannabis exposure occurring during
adolescence, with the associations between later drug abuse predicted by prior
cannabis abuse decreasing with the age at which cannabis abuse began
(Fergusson et al. 2006). This effect has also been exhibited preclinically as well,
where rodents exposed to THC during adolescence increase self-administration to
drugs of abuse in adulthood (Ellgren et al. 2007). Additionally, it has been
previously established that adolescents in general drink more than adults in
various preclinical models of voluntary ethanol seeking (Bergstrom et al. 2006).
The results from these experiment support the hypothesis that adolescent
exposure to THC will increase ethanol seeking while adult exposure does not have
the same effect.
An added aspect of these studies is examination of the effects of NAC on
cognitive deficits induced by adolescent THC exposure. NAC treatment concurrent
with THC and CIE exposure was able to prevent deficits in cognitive flexibility as
well as have an effect on THC induced increases in ethanol seeking. While NAC
has been shown to affect a wide variety of brain systems, its function as a
neuroprotective agent could be a potential mechanism for action for these effects
(Tardiolo et al. 2018). NAC has been shown to cross the blood-brain-barrier in
animal studies and can affect antioxidant pathways as well as regulate
glutamatergic signaling (Farr et al. 2003). Due to THC and ethanol’s ability to
impair glutamate homeostasis in the prefrontal cortex, the regulatory action of NAC
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on this system may be responsible for the pro-cognitive effects of NAC observed
in these studies (Gilbert et al. 1991).
In summary, these experiments revealed that adolescent exposure to THC and
ethanol leads to impairments in cognitive flexibility. This deficit was associated with
perseveration in set-shifting testing. Furthermore, exposure to THC during
adolescence leads to increases in ethanol seeking during self-administration.
Finally, NAC was effective at preventing drug induced alterations in cognitive
flexibility, potentially due to its effects on prefrontal glutamate homeostasis. These
data provide further evidence of the detrimental effects of adolescent THC
exposure on prefrontal cortex reliant behaviors and establish a treatment effect of
NAC.

THC and ethanol exposure during adolescence leads to heightened responding to
fear stimuli through increases in prelimbic activity
To examine the effects of adolescent drug exposure on future response to fear
stimuli, animals were exposed to vaporized THC and ethanol during midadolescence before being tested in fear conditioning paradigms. The ability of NAC
to impact drug induced alterations in fear responding was examined along with invivo recordings from the PrL during the presentation of fear stimuli. These studies
found that adolescent exposure to THC and ethanol results in heightened
behavioral responding during fear conditioning along with an increase in PrL
signaling in response to each shock presentation. Additionally, when NAC was
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administered concurrently with each drug exposure, the effects of THC and ethanol
on both behavioral freezing responses as well as PrL signaling alterations were
prevented. These studies revealed the deleterious effects of adolescent exposure
to THC and ethanol and provide evidence of impairments in PrL function as a
contributing factor that may underlie the clinical relationship between adolescent
drug exposure and future susceptibility to developing PTSD following trauma
exposure.
These results add to the present literature examining the effects of THC and
ethanol on stress responses. Cannabis is commonly used in an attempt to
decrease anxiety, but THC is known to be anxiogenic, especially when it is taken
at higher concentrations (Sharpe et al. 2020). This relationship has been
demonstrated across a wide variety of preclinical tests of anxiety and in clinical
examinations (Rock et al. 2017, Raymundi et al. 2020). More recently, the longterm effects of THC on anxiety disorders has become a topic of study. Clinical
studies have examined this relationship by putting chronic cannabis users through
a fear conditioning paradigm and found that, during conditioning, cannabis use
was associated with increases in threat generalization to safety stimuli (Papini et
al. 2017). This reduction in differentiation between safe and threatening stimuli was
also associated with impairments in fear extinction (Papini et al. 2017). These
effects have been further investigated preclinically in the adolescent population.
Specifically, studies have shown that adolescent animals exposed to THC exhibit
alterations in fear learning after being exposed to a stressor, but this effect was not
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observed when THC exposure occurred during adulthood (Saravia et al. 2018).
Additionally, adolescent exposure to chronic ethanol has been shown to have
variable behavioral effects on fear conditioning depending on the ethanol exposure
paradigm, fear conditioning protocol, and timing of exposure. Due to varying
ethanol and fear exposure paradigms, these studies have found no effects on fear
conditioning (Broadwater and Spear 2013), impairments in learning during
conditioning (Stephens et al. 2005), or heightened responding (Moberg et al. 2017)
following ethanol exposure. By using chronic intermittent ethanol exposure
followed by exposure to 12 tone/shock pairings during conditioning, our results
provide novel data regarding ethanol’s ability to increase responding during fear
conditioning.
The effects of THC and ethanol observed during the behavioral paradigms
completed in these studies were associated with signaling alterations in the PrL
subregion of the prefrontal cortex. Generally, activity in the PrL cortex has been
shown to correlate with freezing behavior during conditioning paradigms (BurgosRobles et al. 2009). Exposure to either THC or ethanol during adolescence has
been previously shown to alter the development and morphology of this region.
During adolescence, the prefrontal cortex is uniquely situated to be affected by
drugs of abuse that may affect the ongoing developmental pruning (Pattwell et al.
2016). In rodent models, THC exposure has been shown to disrupt developmental
processes in the PrL subregion of the prefrontal cortex by altering gene networks
that are responsible for dendritic development (Miller et al. 2019). Specifically,
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overactivity at cannabinoid 1 (CB1) receptors in the prefrontal cortex during
adolescence can lead to dysregulation of glutamatergic signaling at inhibitory
interneurons leading to impaired development of these cells and ultimately
resulting in downregulated inhibitory control in this region (Caballero and Tseng
2012). These findings are paralleled by clinical data demonstrating that those with
a history of adolescent cannabis exposure exhibit alterations in both functionality
and volume of the prefrontal cortex (Medina et al. 2009, Orr et al. 2013). Similar
impairments in prefrontal cortex development have been observed as a result of
adolescent alcohol exposure (Squeglia et al. 2014). The prefrontal cortex is known
to be especially susceptible to the deleterious effects of alcohol, and significant
differences in both gray and white matter have been observed following adolescent
alcohol use (De Bellis et al. 2005, Medina et al. 2008). Given the ongoing
development of the PrL as well as the ability of THC and ethanol to affect this
region, these alterations could underlie the behavioral and signaling alterations
observed as a consequence of adolescent drug exposure in the present studies.
The overlap between THC and ethanol’s effects is most pronounced in the
prefrontal cortex and, therefore, NAC could be working in this area to prevent the
increased reactivity to fear stimuli observed in these experiments. In clinical
studies, NAC has been shown to regulate glutamate levels in the prefrontal cortex
(McQueen et al. 2018) as well as functional connectivity of these regions (Mullier
et al. 2019). Additionally, NAC has the ability to promote regulation of glutamate
homeostasis in patients with substance abuse, including adolescents that exhibit
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cannabis dependence (Gray et al. 2010). Therefore, given THC and ethanol’s
effects on prefrontal cortex glutamate homeostasis, NAC could be acting through
this pathway to reduce increases in prelimbic signaling and behavioral responding
during fear conditioning following THC and CIE exposure.
In summary, these experiments determined that adolescent exposure to THC
and ethanol results in heightened behavioral responding during fear conditioning
that is associated with increases in PrL signaling in response to fearful stimuli.
These results support the hypothesis that drug exposure during adolescence can
lead to neurobiological alterations that cause a predisposition to developing fear
cue related disorders such as PTSD, and that normalization of glutamatergic
functioning in the PFC could serve as a pharmacological method of preventing
these deleterious effects.

Summary
The overall goal of this dissertation was to determine the effects of stress,
ethanol, and THC exposure on behavioral and neuronal responses to future
exposure to fear and drug cues. To this end, experiments were completed using
multiple behavioral models of stress and drug exposure, including fear conditioning
and restraint stress accompanied by ethanol self-administration, chronic
intermittent ethanol, and exposure to vaporized THC. Surgical techniques
including microinjections, optogenetics, and fiber photometry were also used to
examine the activity of the prefrontal cortex during these behavioral tasks. Further,
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the pharmaceutical compounds CDPPB and N-acetylcysteine were used to
prevent and reverse both stress and drug induced behavioral and signaling
deficits. In total, the studies completed within this dissertation establish multiple
behavioral deficits that occur as a result of stress and drug exposure, determined
the neuronal localization of these effects in the prefrontal cortex, and used readily
available pharmacological compounds to treat these impairments. These data
supply valuable information regarding the underlying circuitry involved in common
psychiatric disorders such as post-traumatic stress disorder and substance use
disorder and help to further the field regarding the use of glutamatergic modulation
as a treatment strategy.
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